Functional MRI Correlates of Schizophrenia Negative Symptoms during Auditory Oddball Task and Resting State by Shaffer, Joseph
 FUNCTIONAL MRI CORRELATES OF SCHIZOPHRENIA NEGATIVE SYMPTOMS 
DURING AUDITORY ODDBALL TASK AND RESTING STATE 
 
 
 
 
Joseph James Shaffer Jr. 
 
 
 
 
Dissertation submitted to the faculty at the University of North Carolina at Chapel Hill in partial 
fulfillment of the requirements for the degree of Doctor of Philosophy in the Curriculum in 
Neurobiology in the School of Medicine. 
 
 
 
 
 
 
Chapel Hill 
2015 
 
 
 
 
 Approved by: 
 Aysenil Belger 
 Donita Robinson 
 Paul Manis 
 Gabriel Dichter 
 Diana Perkins 
 Karen Grewen 
  Tim Elston
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2015 
Joseph James Shaffer Jr. 
ALL RIGHTS RESERVED
iii 
 
ABSTRACT 
Joseph James Shaffer Jr: Functional MRI Correlates of Schizophrenia Negative Symptoms 
during Auditory Oddball Task and Resting State 
(Under the direction of Aysenil Belger) 
 
Background: The negative symptoms, including flattened affect, poverty of speech, avolition, 
and anhedonia, are important aspects of schizophrenia for which there are no effective 
treatments. Understanding the neural basis of these symptoms is an important step in developing 
therapies for treating these symptoms. Few studies have addressed this question, and most have 
treated negative symptoms as a singular category. We therefore utilize two large functional 
magnetic resonance imaging (fMRI) datasets to test the relationship between individual negative 
symptoms and functional activation and resting-state functional connectivity. 
Methods: The relationship between the severity of negative symptoms in schizophrenia patients 
and functional activation during an auditory oddball task (n = 89) and resting-state functional 
connectivity (n = 172) was assessed using correlation analysis and by contrasting patients with 
high severity symptoms with those with low severity symptoms in two datasets.  
Results: Activity and connectivity within limbic, striatal, default mode, and sensory processing 
networks were associated with negative symptoms and were differentially associated with 
individual negative symptom domains from the Scale for the Assessment of Negative Symptoms. 
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Discussion: Our findings suggest that researchers should treat negative symptoms separately 
Furthermore, our results indicate a relationship between negative symptoms and a failure to 
suppress default-mode and sensory networks. 
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CHAPTER 1: THE NEGATIVE SYMPTOMS OF SCHIZOPHRENIA 
1.1 Introduction 
 Schizophrenia is a chronic psychiatric illness that affects approximately 0.7% of the 
population[1]. While there is a known genetic component to schizophrenia risk, various 
environmental factors such as drug usage and stress are known to be key risk factors[1]. Disease 
onset typically occurs during late adolescence or early adulthood [2]. Schizophrenia, like other 
psychiatric disorders, is diagnosed based on a pattern of symptoms according to the guidelines 
provided by the Diagnostic and Statistical Manual (DSM-V). As a result, schizophrenia is a 
fairly heterogeneous disorder [1, 3].  
The symptoms of schizophrenia include hallucinations, delusions, lack of motivation, 
flattened affect, cognitive disorganization, and attention problems. These symptoms are typically 
divided into three categories; cognitive disorganization, positive, and negative. Disorganization 
symptoms include cognitive deficits, diminished working memory, and attention problems. The 
positive symptoms of schizophrenia include the classic symptoms of psychosis such as 
hallucinations and delusions. These symptoms are called “positive” because they are thought of 
as a gain of function. In contrast, the negative symptoms of schizophrenia are thought of as a loss 
of function and include a set of deficits in emotional expression and motivation. Interest in these 
deficit symptoms has a long history. Emil Kraepelin and Eugen Bleuler both considered them to 
be core features of their respective definitions of dementia praecox [4] and schizophrenia [5].  
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The negative symptoms include the following: 
Flattened Affect – diminished or absent emotional expressiveness, flat/monotone speechAlogia 
– a poverty of speech, speech is reduced in frequency or content 
Anhedonia – loss of the experience of pleasure in daily activities 
Apathy – diminished interest in activity, future, life, etc. 
Avolition – lack of motivation to initiate activity 
Asociality – lack of interest in social activity, withdrawal from social life 
1.2 Clinical Characteristics 
Clinically speaking, negative symptoms are difficult to diagnose and treat. Like nearly all 
of the symptoms of neuropsychiatric illness, negative symptoms must be identified through 
patient interview and behavioral observation. The negative symptoms can be subtle, as 
diminished emotional expression and motivation don’t stand out to patients or clinicians in the 
same way as hallucinations might. Furthermore, the symptoms themselves can complicate the 
clinical interview process. For instance, it can be quite difficult to discern whether a calm and 
quiet patient is instead suffering from severe apathy and alogia. Likewise, deficits in emotional 
expression may make it difficult to describe feeling a lack of motivation. In practice, teasing out 
these symptoms is largely a matter of training and experience; however structured interviews can 
help clinicians to uncover these symptoms.  
Complicating this further is the fact that not all negative symptoms are primary to 
schizophrenia. Patients may experience deficits in motivation or emotional expression as a result 
of other factors such as co-morbid psychiatric illnesses such as depression or as a side-effect of 
their medication [6-8]. Treating these secondary symptoms requires that the underlying cause be 
removed. Treatment for co-morbid psychiatric illness, for instance, may alleviate these 
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secondary symptoms. Extra-pyramidal side-effects of anti-psychotic medications, such as 
involuntary muscle movements, tremors, and spasms as well as Parkinson’s-like symptoms, can 
also cause secondary negative symptoms. These side-effects are more common in typical anti-
psychotics such as haloperidol or chlorpromazine than in newer, atypical antipsychotic 
medications such as clozapine, risperdone, aripiprazole, or olanzapine, so changing a patient to a 
newer anti-psychotic medication may alleviate these symptoms. Supplementation with anti-
cholinergic drugs may also be used to help alleviate these symptoms. Additional negative 
symptoms may also accompany psychotic episodes [6, 7]. It is less clear whether such phasic 
negative symptoms should be categorized as secondary symptoms or whether they should be 
addressed as a separate category, however these symptoms can likewise be effectively treated by 
removing the underlying cause, in this case, by treating the psychotic episode.  
In general, primary negative symptoms are considered treatment-resistant [6, 8, 9]. The 
antipsychotic medications that are known to be effective in treating the symptoms of psychosis 
have little to no effect on these negative symptoms. As noted above, these medications may even 
exacerbate or cause secondary negative symptoms. Research into other pharmaceutical therapies 
has been largely inconclusive and there are currently no FDA-approved drugs for the treatment 
of negative symptoms in schizophrenia.  
Despite the difficulty in diagnosing and treating negative symptoms, they represent a 
critical unmet need in clinical care. Negative symptoms are associated with disease prognosis, as 
more severe negative symptoms are correlated with worse outcomes [6, 9]. Furthermore, 
negative symptom severity is negatively correlated with quality of life. There has been some 
success in treating negative symptoms using psychosocial therapies. Such therapies are focused 
on building social and vocational skills, and while they have been shown to be beneficial for 
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patient quality of life, they have not been shown to actually reduce the severity of negative 
symptoms [7].     
1.3 Identifying the Biological Basis of Negative Symptoms 
The underlying etiology of these negative symptoms poses an important question for 
researchers for three reasons. First, the lack of effective treatments for these symptoms 
represents an unmet clinical need. Second, the stability, treatment resistance, and co-occurrence 
of negative symptoms suggest that they are of primary importance in understanding 
schizophrenia. Third, the relationship between motivation, decision making, and emotional 
processing lies at the heart of understanding the negative symptoms of schizophrenia also lies at 
the heart of understanding cognition in general.   
1.4 Measurement 
In order to research negative symptoms it is necessary to be able to measure them in a 
systematic and quantitative fashion. Researchers share the same limitations as clinicians when it 
comes to recognizing these symptoms, however a variety of tools now exist to help identify and 
quantify negative symptoms. These tools rely on clinical interviews carried out by trained raters 
[10-17] and include the Scale for the Assessment of Negative Symptoms (SANS)[10-12], the 
Positive and Negative Syndrome Scale (PANSS)[14], the Brief Psychiatric Rating Scale 
(BPRS)[15], the Schedule for the Deficit Syndrome (SDS)[17], and the Negative Symptom 
Assessment (NSA)[16]. These rating scales vary in terms of precisely which symptoms they 
include and emphasize, and also in the time period that they cover, but have demonstrated 
validity when compared against each other [18-20]. 
SANS - The SANS along with the PANSS is one of the most frequently used rating scale for 
research purposes. It was first published in the early 1980’s by Nancy Andreasen [10-12]. The 
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SANS consists of 20 domain spread across 5 negative symptom categories (Flat Affect, Alogia, 
Anhedonia/Asociality, Avolition/Apathy, and Attention). Raters are asked to rate the severity of 
each of the 20 domains on a scale from 0 (not present) to 5 (severe) [10-12, 20, 21].  
PANSS - The PANSS was first published in 1987 by Stanley Kay, Lewis Opler, and Abraham 
Fiszbein [14]. The PANSS consists of 30 items, each rated on a scale from 1 (absent) to 7 
(severe) based on the preceding 2 weeks. These items are divided into three categories, positive, 
negative, and general psychopathology. There are 7 items in the negative scale including blunted 
affect, emotional withdrawal, poor rapport, passive/apathetic social withdrawal, difficulty in 
abstract thinking, lack of spontaneity/ flow of conversation, and stereotyped thinking [14, 22, 
23].  
BPRS - The BPRS was first published in 1962 by John Overall and Donald Gorham [15]. A total 
of 24 symptoms are measured with a rating from 1 (not present) to 7 (very severe) based on the 
previous 2-3 days. The BPRS does not categorize symptoms as positive or negative per se, but 
items on the scale including self-neglect, blunted affect, emotional withdrawal, motor 
retardation, tension, and uncooperativeness roughly reflect the negative symptom category.  
SDS - The SDS was first published in 1989 [17] and its purpose is to segregate patients based on 
the presence of deficit syndrome by measuring the presence of two or more primary negative 
symptoms over the preceding 12 months. The SDS includes restricted affect, diminished 
emotional range, poverty of speech, curbing of interests, diminished sense of purpose, and 
diminished social drive. These symptoms are rated for severity between 0(absent) and 4(very 
severe) and based on whether they are primary and stable (yes, no, N/A) [17, 24-27].  
NSA - The NSA was first published in 1989 by Larry Alphs [16]. Originally it contained 26 
items, but a 16 item version, the NSA-16, is more commonly used. A 4 item version, the NSA-4 
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has also been created. Symptom severity ratings on the NSA are anchored to standardized 
criteria and range from 1-6. The NSA-4 includes the restricted speech quantity, reduced range of 
emotion, reduced social drive, and reduced interests items from the NSA-16 [16, 18, 27-31]. 
1.5 The Validity of the Negative Symptom Dimension 
The division of schizophrenia symptoms into three categories; positive, negative, and 
disorganization; has been well supported by decades of research [21, 22, 32-35]. The bulk of this 
research has come in the form of studies that have measured the occurrence of these symptoms in 
large patient populations and have used factor analysis to group symptoms based on co-
morbidity. Studies by several groups have found that a 3-factor model best explains the pattern 
of symptom occurrence in patient populations, and have been consistent in their grouping of 
symptoms. Liddle [34] found three symptom factors in a group of 40 patients, with one factor 
consisting of primarily negative symptoms such as poverty of speech, decreased spontaneous 
movement, unchanging facial expression, paucity of expressive gesture, affective non-
responsivity, and lack of vocal inflection. Andreasen et al. [36] similarly identified 3 factors 
using a larger patient group of 243, with one comprised mainly of negative symptoms including 
avolition, anhedonia, and affective flattening. Arndt et al. [37] also found a similar division of 
symptoms and furthermore found that longitudinally, the negative factor was more stable, 
echoing clinical observations. Arndt et al. also found that the severity of symptoms within each 
category tended to fluctuate together rather than separately. Taken together, these studies suggest 
that: 1. Negative, positive, and disorganization symptoms occur independently from each other; 
2. Negative symptoms tend to co-occur; and 3. Negative symptoms are more stable over the 
course of the illness. 
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Factor analysis studies have also explored the relationship between negative symptoms. 
Liemburg et al. [38] identified two factors within the negative symptoms that correspond to 
emotional expressiveness and avolition respectively within a patient group of 664. They then 
confirmed this analysis using a second cohort of 2172 patients with schizophrenia. The first 
factor was comprised of the lack of spontaneity, poor rapport, flat affect, motor retardation, 
mannerisms and posturing, and avolition symptoms on the PANSS. The second factor included 
passive/apathetic social withdrawal, emotional withdrawal, and active social avoidance.  A 
cluster analysis by Straus et al. [39] had similar findings. They used principal component 
analysis (PCA) on a group of 199 patients based on the SANS, which revealed that two factors 
explained 76.8% of the variance in the sample. An emotional expression factor was comprised of 
flat affect and alogia items while an avolition factor was made up of the avolition and anhedonia-
asociality symptoms. Furthermore they found that patients tended to either have severe 
symptoms of one of these two categories or low severity in both. This analysis was confirmed 
using a second cohort of 169 patients who met the criteria for schizophrenia’s deficit syndrome 
based on the SDS. During validation, PCA was carried out on scores from the SDS rather than 
the SANS, and also supported a two-factor model of negative symptoms. An emotional 
expression factor was identified that was composed of the restricted affect, diminished emotional 
range, and poverty of speech symptom categories from the SDS while an avolition-apathy factor 
was comprised of curbed interests, diminished sense of purpose and diminished social drive 
symptoms.  
1.6 Pharmacological Evidence 
For many years, the etiology of schizophrenia was thought to be a dysregulation in 
dopaminergic function, an idea encapsulated in the dopamine hypothesis of schizophrenia [40-
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42]. This hypothesis is largely based on pharmacological evidence, namely that D2 dopamine 
receptor antagonists such as typical and atypical antipsychotic medications are therapeutically 
effective for treating the symptoms of psychosis and that dopamine agonists such as cocaine and 
amphetamines can be used to trigger psychosis symptoms in people without schizophrenia. 
However, in its original form, this hypothesis does not account for schizophrenia’s negative 
symptoms. D2 antagonist drugs are not particularly effective at treating negative symptoms. 
Likewise, disease models that utilize cocaine or amphetamines in order to mimic schizophrenia 
fail to trigger the negative symptoms [43]. These findings suggest that the etiology of 
schizophrenia, especially of negative symptoms, is not as simple as dopaminergic dysfunction 
[40, 41].  
Interestingly, pharmacological models of schizophrenia that use ketamine do mimic the 
negative symptoms of schizophrenia. Pharmacologically, ketamine’s main mechanism of action 
is as an antagonist for the NMDA glutamate receptor [44]. Clinically its primary usage is as an 
anesthetic, but at lower doses, it can be used to cause a dissociative state. This dissociative state 
mimics many of the symptoms of schizophrenia. In order to account for these, and other 
findings, a glutamatergic model of schizophrenia has been proposed that is supported by 
pharmacological, imaging, and genetic evidence [45, 46]. 
1.7 Structural Correlates of Negative Symptoms 
In order to understand the underlying neuroanatomy of negative symptoms, researchers 
have turned to imaging techniques such as magnetic resonance imaging (MRI) and positron 
emission tomography (PET). Early investigations focused on identifying structural differences 
between individual brain regions and negative symptom severity. Results have been conflicting, 
as many have reported no relationship between negative symptom severity and neural anatomy 
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[45, 47-50], however others have identified decreased grey matter thickness throughout the brain 
in patients with more severe negative symptoms. Turetsky et al. [51] found grey matter 
reductions in temporal, medial frontal, and insular cortex as well as in the hippocampus. Others 
have found grey matter volume reductions in the cerebellum [52], the left precuneus, and the 
posterior cingulate [53].  Similarly, Yoshihara et al. [54] have identified a positive correlation 
between grey matter thickness and negative symptoms in the right thalamus. A relationship 
between negative symptom severity and white matter has also been identified. A negative 
correlation between symptoms and white matter volume has been identified near the anterior 
cingulate and right internal capsule [55]. Studies of white matter using diffusion tensor imaging 
(DTI) have added to our understanding of structural correlates of negative symptoms. A negative 
correlation between fractional anisotropy and negative symptoms has been identified in the 
internal capsule, anterior thalamic radiation, parietal portion of the superior longitudinal 
fasciculus, fronto-occipital fasciculus [56], corpus callosum [56-58], medial frontal gyrus [59], 
and inferior frontal white matter [60]. Likewise, a positive correlation has been identified 
between negative symptoms and fractional anisotropy near the right insula [61], left cingulum, 
and left superior longitudinal fasciculus [62]. Chuang et al. [63] divided the negative symptoms 
into an emotional expression category and an avolition category, as suggested by factor analysis, 
and found that only the avolition factor was associated with differences in white matter. 
Specifically they found a negative correlation with white matter in the left anterior limb of the 
internal capsule and with the anterior thalamic radiation. A positive correlation was found with 
the left superior longitudinal fasciculus.    
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Overall, these findings suggest grey matter reduction in limbic and default-mode network 
regions, while white matter abnormalities suggest that wide-scale connectivity problems underlie 
negative symptoms. 
1.8 Functional Correlates of Negative Symptoms during Task Completion 
The use of fMRI and PET has allowed researchers to investigate not only structural 
differences that correlate with the severity of negative symptoms, but to also find functional 
correlates of symptom severity during the completion of targeted behavioral tasks. In their 
comprehensive review, Goghari et al. [64] concluded that negative symptoms were associated 
with the ventro-lateral pre-frontal cortex during executive tasks based on Menon et al.[65] and 
MacDonald et al. [66], with amygdala, hippocampus, and parahippocampal gyrus during 
emotional tasks based on Gur et al. [67]; and Juckel et al. [68], and the ventral striatum during 
reward and conditioning tasks based on Juckel et al. [68], Juckel et al. [69], and Jensen et al. 
[70]. Their review also included one study [71] that found a relationship between negative 
symptoms and activation in the dorsolateral prefrontal cortex during a working memory task, but 
this finding was in conflict with other studies included in the review [66, 72-76]. The 
conclusions of the Goghari review have been supported by several studies using positron 
emission tomography (PET) which  have found a negative correlation between functional 
activity and negative symptom severity within the prefrontal cortex [77-80] and the limbic 
system [81]. PET studies have also identified a similar correlation in the temporal cortex, [82-84] 
an area that was not investigated in the Goghari review. A fMRI study that was not included in 
the Goghari review, Simon et al. [85],  also identified a relationship between negative symptom 
severity and brain activity with the ventral striatum.   
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1.9 Resting State Functional Connectivity 
Increasingly our understanding of psychiatric illnesses points towards dysfunctional 
networks of brain regions. Resting-state functional MRI has served as a useful tool to study brain 
connectivity within schizophrenia during “resting state,” that is, outside of the behavioral 
paradigms of task performance. FMRI data is collected during this period and functional 
connectivity analysis is carried out by measuring time-correlated fluctuations in blood-oxygen 
level dependent (BOLD) signal. The strength of these correlations provides a measure of 
functional, rather than structural connectivity.  
Resting state connectivity exhibits wide-spread differences between the brains of healthy 
controls and schizophrenia patients. Three particular brain networks have been best studied, the 
default mode network (DMN), the salience network (SN), and the central executive network 
(CEN). The DMN is thought to be a task-negative network, showing increased activity in the 
absence of a task. The posterior cingulate or precuneus are often used as seed regions for the 
DMN, however it is also includes medial frontal and temporal cortex regions as well as portions 
of the inferior parietal cortex. In contrast, the SN is a task-positive network, engaged during tasks 
that demand attention. SN consists of the anterior insula, lateral parietal cortex, and dorsal 
anterior cingulate. The CEN is engaged during tasks requiring cognition and includes the 
dorsolateral prefrontal cortex and posterior parietal cortex [86].  
While there are many studies that have explored the relationship between negative 
symptoms and functional activation during a task, fewer have explored the relationship between 
negative symptom severity and resting-state functional connectivity. These studies have 
identified a relationship with negative symptom severity in many of the same networks that have 
been implicated in schizophrenia. Manoliu et al. [86] found that greater negative symptom 
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severity was correlated with decreased connectivity between left anterior insula and other regions 
within SN, namely the right anterior insula and the anterior cingulate. The same study found that 
more severe negative symptoms were correlated with increased connectivity between the SN and 
a right ventral CEN that included the inferior parietal lobule, middle frontal gyrus, middle 
cingulate cortex, and middle orbital gyrus. Pu et al. [87] also implicates connectivity within one 
of these networks, the DMN. They found that decreased connectivity between posterior cingulate 
and precuneus was associated with increased severity of avolition.  
However, some studies have identified correlates of negative symptom severity that do 
not fall within these three networks. Pu et al. [32] also found a relationship between total 
negative symptoms and inter-hemispheric connectivity in amygdala, middle temporal pole, and 
superior orbital frontal cortex, which suggest the involvement of the limbic system. 
Venkataraman et al. [88] found that compared to healthy controls, schizophrenia patients 
exhibited reduced inter-hemispheric connectivity; decreased connectivity between medial 
parietal cortex and the left temporal lobe; and increased connectivity between medial parietal 
cortex and the frontal lobe.  Interestingly, this same study found that negative symptoms were 
negatively correlated with the same medial parietal to prefrontal connectivity that was hyper-
connected in schizophrenia. In contrast, a study of network characteristics by Yu et al. [89] 
identified that average path length was positively correlated and that global efficiency was 
negatively correlated with the severity of negative symptoms using the PANSS and that these 
same features were also present in a contrast between schizophrenia patients and healthy 
controls. 
If we look at findings from studies that have measured functional activation in individual 
brain regions during task completion and from studies that have measured functional 
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connectivity at resting state, we can start to identify networks that are implicated in negative 
symptoms.  
1.10 Rationale 
Individuals with schizophrenia must exhibit some combination of positive and/or 
negative symptoms in order to be diagnosed with the illness; as a result, the population of people 
with schizophrenia expresses a heterogeneous mixture of symptoms and symptom severities. 
Because our current understanding of neurobiology in general indicates that these symptoms 
must be the result of some biological cause, we can see how such diversity would make research 
difficult, as two individuals with schizophrenia may share little underlying pathophysiology. As 
a result, increased attention has been directed towards identifying the neural correlates of 
individual symptoms of schizophrenia and other psychiatric illnesses. The Research Domain 
Criteria (RDoC) portion of the NIMH’s strategic plan underscores the importance of such an 
approach. Focusing on symptoms rather than disorders allows researchers to identify more 
homogenous populations, to explore shared features of separate psychiatric illnesses, and to 
provide more informed interpretations of neurobiological findings. In the case of schizophrenia, 
negative symptoms are a prime target for such research precisely because of their stability over 
the course of the illness and their resistance to anti-psychotic medications. These features makes 
it easier to acquire reliable symptom data, and suggest a more central role of these symptoms in 
the disease pathology.  
Previous attempts to identify neural correlates of negative symptoms have largely 
focused on negative symptoms as a single measure. This approach is supported by factor-analytic 
studies which have shown that negative symptoms tend to occur together independently of 
positive symptoms [21, 33, 36, 37]. These studies have shown that the severity of negative 
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symptoms is associated with both structural and functional brain differences. Several studies 
have identified decreased grey matter in regions of the prefrontal and temporal cortices as well as 
in limbic regions and cingulate cortex [51, 53, 54, 62, 63]. Decreased frontal lobe volume has 
also been associated with increased negative symptoms [48, 51], and DTI studies have identified 
decreased white matter in the prefrontal cortex of patients with high negative symptom scores 
and a negative correlation between negative symptoms and white matter integrity [49, 62, 63, 
78]. Functional studies have echoed these results and have found a negative correlation between 
brain activity in the temporal cortex, ventral pre-frontal cortex, left thalamus, ventral striatum, 
and dorso-lateral pre-frontal cortex and the severity of negative symptoms [64]. These findings 
suggest that negative symptoms might be associated with frontal, temporal, limbic, and striatal 
regions, and indeed, these regions are thought to be responsible for the processing of planning, 
emotion, motivation, and speech. However, while an individual who expresses one negative 
symptom is more likely to express other symptoms, not all patients share all of the same negative 
symptoms [32, 90], suggesting that the individual symptoms reflect distinct neural correlates. 
Few studies have investigated individual negative symptoms and measured their relationship to 
brain imaging data in patients with schizophrenia. This is likely because the typical sample size 
of an MRI study is small, which does not provide sufficient power to assess such relationships. 
In order to overcome this hurdle, we will address this question by leveraging two large datasets 
generated as part of the functional Biomedical Informatics Research Network (fBIRN) 
consortium. Combined, these datasets consist of structural and functional imaging data from 
approximately 250 patients with schizophrenia and a similar number of control individuals. By 
using such large datasets, we expect to identify the relationship between individual negative 
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symptoms such as flatness of affect, poverty of speech, anhedonia, apathy, and attention and 
neural circuitry using structural, functional, and resting-state functional imaging data.  
1.11 Summary and Specific Aims 
Schizophrenia is a disorder characterized by a collection of diverse symptoms including 
“positive” symptoms such as hallucinations, delusions, and bizarre or disorganized thoughts; and 
“negative” symptoms including deficits in emotional expression, motivation, experience of 
pleasure, and attention.  The negative symptoms are of particular interest because they are more 
strongly associated with disease outcome, quality of life, and other clinical measures. Negative 
symptoms remain relatively constant over the course of the illness, and likewise are resistant to 
current medical treatments. These characteristics point to negative symptoms as an important 
target for research. Identifying the underlying mechanisms of these symptoms may improve 
medical treatment for schizophrenia and help elucidate the etiology of the disorder.  
Decades of research in human cognition, sensory perception, and psychiatric illnesses 
have shown that the brain is organized into functional networks that connect diverse anatomical 
regions. It is speculated that psychiatric illnesses like schizophrenia are related to functional 
changes in these networks rather than focal lesions. Advances in EEG and functional MRI 
research have suggested multiple regional and functional abnormalities in schizophrenia. More 
recently, measures characterizing intrinsic connectivity networks such as resting state fMRI have 
opened new and robust avenues of mapping functional networks in the brain and in disease 
conditions. Considering the diverse patterns and severities of symptoms within schizophrenia, 
we might expect that the brain networks underlying negative symptoms may be differentially 
related to different domains of symptoms. In order to identify such networks, our project has two 
specific aims. 
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Aim 1: To measure the relationship between severity of individual negative symptoms and 
functional activity during an auditory oddball task. The relationship between BOLD activation 
in response to the oddball target and severity of negative symptoms will be assessed by 
contrasting patients based on the severity of their symptoms and by measuring the correlation 
between symptom severities and functional activation. The severity of total negative symptoms 
has been associated with decreased functional activity in frontal and temporal areas which are 
known to be interrogated by auditory oddball tasks. We expect that individual negative 
symptoms will be correlated with patterns of functional activity that are distinct from each other 
during the oddball task.  
Aim 2: To identify functional networks that are related to individual negative symptom severity 
in schizophrenia using resting-state functional MRI. The relationship between time-correlated 
spontaneous fluctuations in BOLD signal during resting state and the severity of negative 
symptoms will be assessed by contrasting patients based on the severity of their symptoms and 
by measuring the correlation between symptom severities and functional connectivity. We expect 
that the severity of individual negative symptoms will be associated with connectivity in fronto-
limbic, fronto-striatal, fronto-parietal, and striato-limbic networks. Furthermore, we expect that 
individual negative symptoms will be related network connectivity differently from each other. 
The application of these techniques in schizophrenia should allow for improved 
identification of neural correlates of clinical symptoms in schizophrenia. These neural correlates 
may help researchers to develop better tests for new medical treatments and to select less 
heterogeneous groups for research based on measurable biomarkers.  
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CHAPTER 2: NEURAL CORRELATES OF SCHIZOPHRENIA NEGATIVE  
SYMPTOMS DURING AN AUDITORY ODDBALL TASK 
2.1 Background 
Negative symptoms in schizophrenia patients include diminished motivation, affective 
responsiveness, speech, movement, social engagement, and hedonic pleasure, and are associated 
with poor functional outcome and quality of life [91]. They are of particular interest due to their 
resistance to current antipsychotic treatments [8, 33, 64] and their persistence over the course of 
the illness [8, 64]. The presence of negative symptoms in unaffected first-degree relatives [64, 
92] further suggests that the neural underpinnings of these deficits may be associated with a 
genetic liability for schizophrenia. Negative symptoms have a high internal consistency and vary 
in severity independently of positive symptoms such as hallucinations and delusions [33]. 
Improvements in negative symptoms are associated with improved functional outcomes 
including independent living skills, social functioning, and role functioning [31].Targeting them 
may have significant functional benefits, but identification of reliable targets for the treatment of 
negative symptoms remains an unmet clinical need [90, 93-95].   
While severity of negative symptoms is often evaluated by measuring individual symptom 
ratings, negative symptoms tend to co-occur[33]. Some recent factor-analytic studies have 
suggested that negative symptoms can be divided into two categories; one related to avolition, 
comprised of avolition/apathy and anhedonia/asociality, and a second related to emotional 
expressiveness, comprised of flat affect and alogia [32, 38, 39, 96]. It remains unclear whether
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all negative symptoms share the same neural pathology, even when they are strongly related, as 
suggested by factor-analytic approaches.  
Elucidating the neural correlates of negative symptom severity in schizophrenia and its 
modulatory effects on cognitive function in schizophrenia, is a vital step towards identifying 
relevant endophenotypes
 
[33, 64], uncovering the pathophysiological mechanisms that underlie 
them, and developing targeted interventions [8]. A review of 25 schizophrenia studies showed 
that BOLD activity in ventro-lateral prefrontal cortex and ventral striatum was inversely 
associated with negative symptom severity during executive functioning and reward conditioning 
tasks respectively [64]. Other studies have identified a correlation between the severity of 
negative symptoms and cortical thickness in prefrontal cortex, superior temporal cortex, and 
medial temporal cortex including the hippocampus [8]. Furthermore, fMRI studies have 
identified decreased functional activation and connectivity within these regions [8, 64] . As 
negative symptoms represent a complex aggregate of emotional and motivational deficits, we 
expect correlations between functional activity during the task and negative symptom severity to 
vary by symptom subtype. Therefore, in this study, we examine correlations between functional 
activation and individual negative symptom domain severity measures obtained using the SANS 
[10]. Few studies have addressed these component symptoms separately; however, this approach 
is pertinent to research efforts to identify research domains across neuropsychiatric disorders 
such as bipolar disorder (BD) and major depressive disorder (MDD). Clinically, the combination 
of these negative symptoms, when persistent, constitutes the Deficit Syndrome [97] that is not 
present in BD or MDD; however individual symptoms such as anhedonia are present across all 
three disorders. The goal of this work is therefore to compare the neural correlates of domains of 
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negative symptoms from the SANS (flat affect, alogia, anhedonia/asociality, avolition/apathy, 
and attention deficits) rather than their effects when grouped together.  
In a retrospective analysis, we used an auditory oddball task consisting of a series of 
standard tones with rare target tones of a different frequency. This task has been used to 
investigate differences in attention related to auditory mismatch and target detection between 
healthy controls and patients with schizophrenia in hundreds of studies since the 1970s [98]. In 
electroencephalography-based studies, schizophrenia patients exhibit a decrease in the amplitude 
of the P300, which is thought to indicate identification of rare targets, during oddball tasks [98-
101] and diminished mismatch negativity (MMN) component thought to reflect an inability to 
properly shift attention [100, 102-104]. P300 has been shown to correspond with negative 
symptoms in schizophrenia [100, 105, 106]. FMRI studies of schizophrenia have shown 
decreased activity in frontal [102, 103, 107], temporal [79, 103, 107], anterior cingulate [102], 
posterior cingulate [107], insula [102, 107], visual [102], and parietal cortex [102, 103] as well as 
in sub-cortical structures such as the striatum [107]
 
and thalamus [102, 107] in response to the 
target tone. Many of these regions have been found to be associated with negative symptom 
severity [8, 64, 108] It is therefore highly likely that individual differences in negative symptom 
severity may interact with activation of neural systems engaged during attentional and executive 
processing. Our goal is to identify correlates between regional brain activity and the severity of 
individual negative symptoms from the SANS.  
The large multisite function Biomedical Informatics Research Network (fBIRN) MRI 
dataset provides a unique opportunity to examine associations between brain physiology and 
symptom severity. FBIRN previously used this task to investigate correlates of hallucinations in 
schizophrenia patients [79]. Ford et al. [79] reported that patients who tended to hallucinate 
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showed decreased activity in left primary auditory cortex when compared with patients who 
tended not to hallucinate. To extend this work, we now examine correlations between negative 
symptoms and the BOLD response to target stimuli in this fMRI auditory oddball dataset from 
the fBIRN study. One previous study carried out by Wolf et al. [108] tested the relationship 
between negative symptom severity and brain activity during an auditory oddball task. In that 
study, left dorso-lateral prefrontal cortex and ventral striatum activation was correlated with 
negative symptom severity during the response to distractor stimuli (but not targets). The fBIRN 
implementation of the auditory oddball task does not include distractor sounds, however, in 
contrast to the findings of Wolf et al.; we expect that given robust differences in brain activity 
between healthy control individuals and people with schizophrenia during the target task 
condition, that this brain activity should also show correlations with clinical symptom severity, 
including the severity of negative symptoms. Ultimately the study performed by Wolf et al. had a 
small sample size (n=17), which may have been too small to measure this effect [108].  
We hypothesized that severity of total negative symptoms in patients with schizophrenia 
will correlate with reduced activation in response to target tones [102, 109]. Furthermore, we 
expected that the individual categories of negative symptoms would correlate with specific 
regions of brain activity during completion of the task. Finally we expected that the patterns of 
individual symptom-correlated brain activity would differ between symptom categories. We 
expect that patients with schizophrenia with severe negative symptoms, particularly avolition and 
anhedonia, will show decreased activity in brain regions related to salience and target detection 
during the oddball task. Affected areas are expected to include frontal and parietal cortex as well 
as the striatum, insula, and anterior cingulate cortex. 
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2.2 Methods 
Participants 
 Eighty-nine adult schizophrenia patients (67 male, 22 female; age M = 38.55, SD = 
11.62) and 106 healthy control individuals (68 male, 38 female; age M = 36.58, SD = 11.82) 
were recruited at 8 research sites (Duke/University of North Carolina , Brigham Women’s 
Hospital, Massachusetts General Hospital, University of California: Los Angeles, University of 
California: Irvine, University of New Mexico, University of Minnesota, and Yale) as part of the 
fBIRN project (Tables 1 and 2).  
Table 1     
Subjects by group, scanner type, and imaging sequence used for each site. 
Site N- HC N-SZ Scanner Sequence 
Duke-UNC 17 17 GE LX 4T Spiral 
BWH 7 7 GE Signa 3T EPI 
MGH 4 6 Siemens 3T Trio EPI 
UCLA 12 5 Siemens 3T Trio EPI 
UCI 20 18 Picker 1.5T Eclipse EPI 
UNM 15 13 Siemens 1.5T Sonata EPI 
UMN 15 14 Siemens 3T Trio EPI 
Yale 16 9 Siemens 3T Trio EPI 
Total 106 89   
 
All participants underwent the Structured Clinical Interview for DSM-IV (SCID) [3] to confirm 
their diagnostic category. Participants were excluded for a current or past substance or alcohol 
abuse problems; head injury; migraine treatment; or an IQ less than 75 as measured using the 
North American Adult Reading Test.  Healthy controls were excluded if they had a first-degree 
family member with a diagnosed psychotic illness. Schizophrenia patients were excluded if they 
showed significant tardive dyskinesia; they were also required to be clinically stable without 
major psychotropic medication changes for the 2 months preceding their participation in the 
study. All subjects were asked to abstain from drinking coffee for 2 hours and from smoking for 
40 minutes previous to the scanning session. Participants were also asked to refrain from 
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consuming more than one alcoholic beverage the night before and were asked to get a good 
night’s sleep. IRB approval was obtained at each site and participants provided written consent 
prior to study participation. Severity of negative symptoms was assessed using the SANS during 
a clinical interview [10-12].  
Auditory Oddball Task 
 Participants were presented with a 2-tone auditory oddball task consisting of a 
1000 Hz standard tone and a 1200 Hz target tone. Stimulus duration was 100ms with a 500ms 
inter-stimulus interval. Target stimuli were rare, occurring in only 5% of trials, or about every 6-
15 seconds (Figure 1). A black fixation cross was presented in the center of a gray screen. 
 Volume was adjusted by the experimenter to 85dB SPL at the headset, to ensure that the stimuli 
could be heard binaurally over scanner noise. Participants underwent 2 practice runs and 4 
experimental runs, each lasting 280 seconds. Runs were preceded and followed by a 15s fixation 
period. 
Participants were instructed to press a button with their right index finger in response to 
the target tone and to do nothing in response to the standard tone. Responses occurring faster 
than 200ms were excluded from the behavioral analysis. Response times were not available from 
one site participating in the study, but are reported for the others. Discrimination was assessed 
using the d’ statistic and was available from all sites. The d’ statistic measures target 
discrimination by utilizing the difference between hit rate and false positive rate, d' = Z (hit rate) 
- Z (false alarm rate), where Z represents the inverse Gaussian distribution. 
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Table 2     
Comparison of demographic data by group showing means, standard deviations, counts, and 
comparison statistics. 
Characteristic Healthy Controls SZ Patients t P 
N 106 89   
Age (years) 36.33±11.82 37.43±11.62 -0.6794 0.4977 
Sex 68 M/38 F 67 M/ 22 F OR: 0.578 0.07584 
Education Level (years) 15.67±2.42 (n = 97) 13.45±1.93 (n = 
73) 
6.3259 1.927e-09 
Handedness 98 R/5 L/3 A 81 R/8 L  0.3847 
Race   OR: 1.18 0.6345 
American Indian/ 
Alaska Native 
1 0   
Asian 9 1   
Native Hawaiian/ 
Pacific Islander 
1 0   
Black/ African 
American 
13 22   
White 79 64   
More than one race 1 0   
Unreported 2 2   
Ethnicity   OR: 1.33 0.627 
Unreported 0 1   
Hispanic/Latino 11 7   
Not Hispanic/Latino 95 81   
SZ = schizophrenia; M = Male; F = Female; L = Left handed; R = Right handed; A = 
Ambidextrous; OR = odds ratio 
 
 
Figure 1: Illustration of auditory oddball Task timing showing the relative timing of standard (1000 Hz) and deviant (1200 Hz) 
tones. 
Imaging Parameters 
Imaging parameters were standardized between sites based on prior work carried out as 
part of the fBIRN project [110-114]. Functional imaging slice orientation was along the Anterior 
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Commissure-Posterior Commissure (AC-PC) line using a single-shot EPI sequence at all sites 
except for Duke, which used a spiral echo sequence (TR = 2000ms, TE = 30ms (3T); 40ms 
(1.5T), flip angle = 90, matrix = 64x64, FOV = 22cm, slices = 27, thickness = 4mm, gap = 
1mm). 
Image Processing 
Image data were processed using the fBIRN Image Processing System (FIPS), which 
relies on functions from the FMRIB Software Library (FSL, www.fmrib.ox.ac.uk/fsl) [115-117]. 
Images were corrected for motion, b0 field irregularities, and slice timing. Brain extraction was 
carried out using FSL and 8mm full-width at half maximum Gaussian smoothing was carried out 
using Freesurfer so that images from all sites were consistently smooth. 
FMRI data processing was carried out using FMRI Expert Analysis Tool (FEAT) Version 5.98, 
part of FSL. Multiple comparisons correction was carried out using cluster-based family wise 
error with an initial threshold of 2.3 and p = 0.05.  
Statistical Analysis 
The statistical analysis of demographic data was carried out using the Welch two-sample 
t-test for continuous variables and Fisher’s exact test for categorical data. Between-group 
behavioral results were also tested using the Welch two-sample t-test.  
Participants were contrasted based on clinical category (HC vs. SCZ). Correlation 
analysis was carried out in the patient group based on severity of total negative symptoms and of 
individual negative symptom categories (flat affect, avolition/apathy, anhedonia/asociality, 
alogia, attention). Symptom scores were also combined into an emotional expression factor (flat 
affect + alogia) and an avolition factor (avolition/apathy + anhedonia/asociality), and FSL was 
used to test the correlation between these domains and functional activation. Demographic 
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variables such as age, gender, and imaging site were used as covariates in these analyses. A 
similar analysis was carried out as a contrast between high and low symptom severity of total 
negative symptoms and of individual symptom measures. These categories were determined by 
dividing participants at the median for each symptom severity.     
2.3 Results 
Behavior 
We found no difference between patients with schizophrenia and healthy controls in d’ (t 
(198) = 1.185, p = 0.2375) or in response time (t (174) = -1.840, p = 0.0674) for target stimuli. 
Furthermore, we found no relationship between total negative symptom severity and d’ (F (24, 
66) = 1.391, p = 0.1468) or response time (F (5, 74) = 0.0551, p = 0.998) within the patient 
group.  
Clinical Symptoms 
Total negative symptom score was highly correlated with the score for each individual 
item, which were all highly correlated with each other (see Table 3). 
Table 3 
Comparison of negative symptom scores by showing means, standard deviations, and correlation values. 
Symptom Flat Affect 
M = 1.73 
SD = 1.49 
Alogia 
M = 1.12 
SD = 1.24 
Avolition/Apathy 
M = 2.29 
SD = 1.33 
Anhedonia/Asociality 
M = 2.48 
SD = 1.44 
Total Negative 
M = 9.07, SD =4.46 
0.77* 0.72* 0.67* 0.66* 
Flat Affect  0.60* 0.40* 0.29* 
Alogia   0.29* 0.26* 
Avolition/Apathy    0.50* 
Anhedonia/Asociality     
df = 87, * p<0.05     
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Schizophrenia vs. Healthy Control 
We found that the schizophrenia group showed decreased activation in response to targets 
in several brain regions compared with healthy controls in a whole-brain voxel-wise analysis 
(Figure 2). Significant clusters of activity are listed in Table 4. These regions included bilateral 
orbitofrontal cortex, inferior frontal gyrus, middle frontal gyrus, frontal pole, frontal operculum, 
insula, anterior cingulate, paracingulate, posterior cingulate, pallidum, putamen, thalamus, 
angular gyrus, supramarginal gyrus, pre-cuneus, intracalcarine cortex, lingual gyrus, and lateral 
occipital cortex; unilateral decreases were seen in right hippocampus and left cuneal cortex. 
There were no regions for which the schizophrenia group exhibited greater activity than patients 
in response to the target tone.  
 
Figure 2 Functional activation differences between healthy controls and schizophrenia patients in response to deviant tone. A) 
Areas where schizophrenia patients showed decreased activation. B) Illustration of slice locations from part A. 
 
Whole-brain Correlation with Clinical Symptoms 
 Whole-brain voxel-wise correlation was performed between the BOLD response to 
targets and negative symptom scores within the schizophrenia group. This analysis was carried 
out for total negative symptom severity and for each of 5 negative symptoms: flat affect, alogia, 
anhedonia/asociality, avolition/apathy, and attention. This allowed us to characterize symptom 
correlations throughout the brain.  
 The total severity of negative symptoms was negatively correlated with target-related 
BOLD activity in several clusters.  
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These clusters (Figure 3, Table 5) include the hippocampus, amygdala, superior temporal cortex, 
fusiform, and thalamus in the right hemisphere; the middle frontal gyrus and lateral parietal 
cortex in the left hemisphere; and the insula, cuneus, and posterior cingulate in both 
hemispheres. 
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Figure 3 Functional activation correlates of negative symptoms in response to deviant tone. A) Regions negatively correlated 
with total negative symptoms. B) Slice locations for A. C) Regions negatively correlated with alogia. D) Regions negatively 
correlated with avolition/apathy. E) Slice locations for C and D. F) Regions negatively correlated with anhedonia/asociality. G) 
Slice locations for F. 
 
Neither flat affect nor attention severity measures correlated with any voxels in the 
analysis; however voxels in several brain regions were negatively correlated with severity of 
alogia, anhedonia/asociality, and/or avolition/apathy (Figure 3, Table 5). Regions showing a 
negative correlation with the severity of alogia include right caudate, left pallidum, and bilateral 
thalamus, posterior cingulate. Regions showing a negative correlation with the severity of 
avolition/apathy symptoms include right fusiform gyrus, right pre-cuneus, bilateral cuneus, and 
posterior cingulate. Regions showing a negative correlation with the severity of 
anhedonia/asociality are similar to those seen for total negative symptoms and include the right 
amygdala, hippocampus, and superior temporal gyrus; left post-central gyrus and middle frontal 
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gyrus; and bilateral thalamus including the dorsal medial and ventral lateral nuclei, insula, 
fusiform gyrus, cuneus, pre-cuneus, and lateral occipital cortex. Interestingly, there were no 
voxels that were significantly correlated with the combined emotional expression factor or with 
the combined avolition factor.  
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Figure 4 Regions where patients with high severity for A) avolition/apathy and B) anhedonia/asociality showed decreased 
activation to deviant tone 
 
Contrast between ‘High’ and ‘Low’ Symptom Severities 
Patients were contrasted based on whether they experienced a ‘high’ or ‘low’ level of 
symptoms for each individual symptom domain based on a median split. There were no voxels 
where patients with more severe symptoms showed increased activity. Patients with ‘low’ 
avolition/apathy severity demonstrated greater activation in left middle frontal gyrus and anterior 
cingulate than patients with ‘high’ severity. Likewise, patients with ‘low’ anhedonia/asociality 
severity showed greater activation in bilateral visual cortex, bilateral insula, right thalamus, right 
orbital frontal cortex, right putamen, right precuneus, and left inferior parietal cortex (Figure 4). 
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2.4 Discussion 
2.4.1 Healthy vs. Patient Group 
Consistent with previous auditory oddball findings, we found that participants with 
schizophrenia had decreased functional activation throughout the brain in response to the target 
tone[107, 118]. These decreases were found in the frontal, insular, cingulate, and parietal cortex 
as well as several sub-cortical structures including the thalamus, caudate, and hippocampus. As 
the fronto-parietal, fronto-limbic, and fronto-striatal networks are important in executive 
functions, this diminished activation is consistent with known impairments in schizophrenia 
[102, 107].  
In contrast, there was no significant difference in behavioral performance between groups 
on this task. The auditory oddball literature is mixed, with some studies reporting behavioral 
differences between groups[89, 103],and others finding no difference[107, 118]. The absence of 
group differences in behavior suggests that the observed differences in functional activation 
between schizophrenia patients and healthy controls are not a consequence of performance, and 
instead reflect the pathology of schizophrenia.  
2.4.2 Total Negative Symptoms  
Group differences in functional activation during auditory oddball tasks are well 
established [102, 108, 119], but little is known about the relationships between auditory oddball 
task activation and symptom severity.  Our results revealed a significant relationship between 
BOLD activity in response to the target tone and the severity of total negative symptoms, alogia, 
avolition/apathy, and anhedonia/asociality. Overall, increasing symptom severity corresponded 
with decreased BOLD activation. These findings contrast with some previous studies[108] that 
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reported the absence of a relationship between BOLD response to targets and negative symptom 
severity as measured by total SANS.  This discrepancy may be attributed to that study’s smaller 
sample size. On the other hand, they did find a relationship between symptom severity and 
BOLD activation to novel stimuli, which were not included in our oddball task. 
Total negative symptoms were negatively correlated with activity in subcortical regions 
including bilateral thalamus and limbic regions such as the right hippocampus and right 
amygdala. Cortical regions that were correlated included bilateral insula, left middle frontal 
gyrus, left lateral parietal cortex, right superior temporal cortex, right fusiform, bilateral cuneus, 
and posterior cingulate. These regions suggest the involvement of several networks including the 
limbic system and fronto-parietal attention networks, but also possibly implicating early sensory 
networks as well.  
2.4.3 Correlates of Individual Symptom Domains 
The severity of anhedonia/asociality was correlated with activity in a qualitatively similar 
set of regions as total negative symptoms. Higher symptom severity was associated with lower 
BOLD response to the target tone in limbic areas such as the right amygdala, right hippocampus, 
bilateral thalamus, and bilateral insula; in higher-order cognitive regions such as the left middle 
frontal gyrus; in default-mode network regions such as the bilateral pre-cuneus; and in early 
sensory regions including bilateral fusiform gyrus, bilateral cuneus, bilateral lateral occipital 
cortex, left post-central gyrus, and right superior temporal gyrus. Rather than being an inability 
to experience pleasure, anhedonia in schizophrenia seems to be related to decreased prediction of 
pleasure[120, 121]. While this study did not use a reward paradigm, decreased BOLD activity in 
vmPFC and ventral striatum have been observed in people with schizophrenia during the 
performance of reward tasks[120]. In the context of our study, decreased activity in brain regions 
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involved in the formation of hedonic memories such as the hippocampus and other limbic areas 
such as the amygdala and insula may underlie a general inability to predict pleasure. We also 
found a negative correlation between anhedonia/asociality and activity in the posterior cingulate 
and precuneus, which are typically considered to be part of the DMN. The DMN is thought to be 
a task-negative network that is reciprocally connected to a variety of other “task-positive” 
networks such as those involved in executive processing and in sensory processing[122]. Several 
studies have shown that patients with schizophrenia have increased DMN activity during the 
completion of neurocognitive tasks which may reflect an inability to turn the DMN “off”[123, 
124]. Our findings seemingly contradict the expectation that symptom severity would be 
positively correlated with DMN activity during task performance. This may be because most 
previous studies are comparing task activation against non-task activation, whereas our data 
results from contrasts between standard and target tones (task vs. task).  
Importantly, activity patterns for alogia and avolition/apathy differed from those that 
correlated with total negative symptom severity. Severity of alogia was associated with 
decreased activity in the bilateral thalamus, right caudate, and left pallidum. These regions are 
key components of the basal ganglia and their involvement here suggests that alogia symptom 
severity may reflect deficits in the ability to engage in voluntary motor behavior. We might, 
however, expect that avolition/apathy would be related to this circuitry as well, but instead, it 
was associated with activity in the right pre-cuneus and bilateral posterior cingulate, which are 
thought to be involved in the DMN; as well as regions typically thought to be involved in visual 
processing including the bilateral cuneus and right fusiform gyrus. While it is difficult to explain 
the involvement of the cuneus and fusiform gyrus, the involvement of the posterior cingulate 
may be similar to its involvement in anhedonia/asociality symptoms.  
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2.4.4 Differences in Individual Symptom Domains 
Most importantly, we found that some individual negative symptoms were associated 
with a different pattern of functional activity than total negative symptoms. The severity of 
alogia and avolition/apathy were both associated with a pattern of activation that was 
qualitatively different from each other and from total negative symptoms. Anhedonia/asociality, 
on the other hand, was associated with a pattern that was nearly identical to total negative 
symptoms, suggesting that this symptom category may dominate our sample. However, severity 
of anhedonia/asociality was not greater than other symptom categories in our sample, nor was it 
more strongly associated with the severity of total negative symptoms. It may also be the case 
that these individual negative symptoms are not truly equal in terms of how closely related they 
are to the core etiology of schizophrenia. In the context of the two-factor model of negative 
symptoms [32, 38, 39, 96], our results suggest a relationship between elements of the “avolition” 
factor and functional activation during the oddball task. Alogia was the only component 
symptom of the “emotional expressiveness” factor to be found to be correlated with functional 
activation in this study. This may be expected given the lack of emotional content in the auditory 
oddball task. Furthermore, alogia may load onto both expression and avolition factors[96], and in 
this context, we may be seeing neural activity related to the “avolition” aspects of alogia rather 
than problems with emotional “expressiveness.” Interestingly, our findings suggest distinct 
correlations between functional activation and avolition/apathy and anhedonia/asociality. This, 
along with our failure to identify any voxels that were significantly correlated with the combined 
anhedonia factors underscores the notion that even though symptoms may be highly interrelated 
clinically, that they do not necessarily share all of the same neurobiological underpinnings. 
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In either case, our findings suggest that the use of broad global symptom dimensions may 
be counter-productive when seeking to characterize higher-order functions. Instead, the usage of 
sub-dimensions may be a more appropriate target for research. However, it is likely that global 
domains such as total negative symptom severity will remain useful for clinical and 
phenomenological purposes, as these negative symptoms tend to co-occur. Our clinical findings 
certainly echo previous findings by demonstrating that the severities of these clinical symptoms 
are highly correlated. All 5 individual symptom categories exhibited a robust correlation with 
total severity, as one might expect. Attention deficits were less strongly associated with total 
negative symptoms and with the other 5 categories, suggesting, as some do[19], that attention 
deficits may be categorized separately from the negative symptoms. Finally, as most individuals 
lacked at least one individual symptom category from the SANS, the distribution of symptom 
severity ratings was not normally distributed. Therefore it is likely that the effect size is small for 
neural correlates of individual negative symptom domains. From a research perspective, this 
suggests that studies that seek to explore the relationship between symptoms and functional 
activity should use targeted enrollment or large samples in order to carry out research on these 
individual symptom categories, as a large fraction of patients will be asymptomatic for any given 
category.  
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CHAPTER 3: FUNCTIONAL CONNECTIVITY CORRELATES OF 
 SCHIZOPHRENIA NEGATIVE SYMPTOMS AT RESTING STATE 
3.1 Background 
While functional MRI studies have identified multiple regions that show altered 
functional activation in patients compared with healthy controls, schizophrenia is ultimately the 
result of dysfunctional neural networks, not individual brain regions [125]. Numerous studies 
have explored differences in resting-state functional connectivity in schizophrenia. Many of 
these studies have focused on a task-negative network of brain that has been named the default 
mode network (DMN). The DMN is most active in the absence of a behavioral task and task 
performance is accompanied by a decrease in activity within this network. The DMN is generally 
thought to exhibit hyper-connectivity in schizophrenia patients [124, 126-128], with decreased 
connectivity within anterior regions [129] that is sensitive to age [130]. Interestingly, this hyper-
connectivity can be found both during and in the absence of a behavioral task, suggesting that a 
failure to disengage the task-negative network may be at least partially responsible for deficits in 
task performance in schizophrenia patients [126]. Power et al. suggest that the DMN is 
structurally similar to sensory networks [131], and functional connectivity [132]and EEG studies 
have shown that early sensory processing is disrupted in schizophrenia [133, 134].  
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Hyper-connectivity has also been shown for thalamic networks in schizophrenia [127], 
which might suggest a failure to coordinate between top-down neural networks and bottom-up 
sensory processing networks and DMN [135, 136]. Furthermore, thalamic dysconnectivity may 
underlie aberrant connectivity in fronto-limbic and fronto-striatal networks [135, 137, 138]. 
Importantly, disruption in these networks has been more closely tied to cognitive, rather than 
negative symptoms in schizophrenia [126, 135, 139].  
Schizophrenia patients have shown decreased connectivity within executive and attention 
networks involving dorsolateral, ventro-lateral, and medial prefrontal cortex and anterior 
cingulate [86, 126, 127, 138-140].   
Direct exploration of negative symptoms has been limited, with studies typically 
including a correlation analysis with symptom measures as a supplementary analysis rather than 
exploring it as the main hypothesis. These studies have shown a correlation between negative 
symptom severity and DMN [86, 136], limbic system [86, 87], and SN regions [86-88]. None of 
these studies have explored individual negative symptom domains separately, except Pu et al. 
[32] who explored the relationship of avolition separately from total negative symptoms. They 
found that avolition was associated with reduced connectivity within the DMN between the 
posterior cingulate and precuneus. We expect that total negative symptoms and individual 
symptoms will be associated with aberrant connectivity within these networks and, because of 
the motivational aspects of negative symptoms, will also be associated with connectivity in the 
striatum. Similar to our study of negative symptoms during the auditory oddball task, we expect 
that these sub-divisions of the negative symptoms will reflect overlapping, but ultimately 
different patterns of dysconnectivity, reflecting differences in the underlying neurobiology of the 
negative symptoms.  
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3.2 Methods 
3.21 Participants 
One hundred and seventy two Adults with schizophrenia (128 male, 119 female; age M = 
38.73, SD = 11.44) and 170 healthy control individuals (119 male, 52 female; age M = 37.52, SD 
= 11.25) were recruited at 8 research sites (Duke-University of North Carolina (Duke-UNC), 
University of Iowa, University of Minnesota, University of New Mexico, University of 
California Irvine, University of California San Francisco, University of California Los Angeles, 
and University of California San Diego) as part of the third phase of the functional Biomedical 
Informatics Research Network (fBIRN) project. There was no difference between groups with 
regard to age, handedness, or ethnicity, but there was a significant difference between groups in 
terms of education level and race (Table 6).  
Exclusion criteria included current or past substance abuse or alcohol abuse problems, 
head injury, treatment for migraines, an IQ <75 (measured using North American Adult Reading 
Test (NAART)). Additionally, healthy controls were excluded if they had a first-degree relative 
with a diagnosed psychotic mental illness (schizophrenia, schizoaffective disorder, psychosis 
NOS, etc.). Schizophrenia patients were excluded for significant tardive dyskinesia and were 
required to be clinically stable with no medication changes in the 2 months preceding their 
participation in the study.  
All participants were asked to abstain from consuming caffeine for 2 hours and from 
consuming nicotine for 40 minutes prior to the scanner session. They were also asked to refrain 
from consuming >1 alcoholic beverage the night before the session and were asked to get a good 
night’s sleep. IRB approval was obtained at each research site and participants provided 
informed written consent prior to participation.  
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Table 6 
Comparison of demographic data for study 2 by group showing means, standard deviations, counts, 
and comparison statistics. 
Characteristic Healthy Controls SZ Patients t P 
N 171 172   
Age (years) 37.52±11.25 38.73±11.44 1.33 0.19 
Sex 119 M/52 F 128 M/ 44 F X
2
=1.91 0.17 
Education Level (years)   X
2
>33 4.50E-74* 
Never Completed HS 3 26   
HS Graduate/GED 11 43   
Some College 45 72   
College Graduate 77 31   
Professional/Graduate 
School 
35 0   
Handedness 163 R/6 L/2 A 158 R/10 L/4 A X
2
= 4.82 0.09 
Race   X
2
= 30.57 3.74E-06* 
American Indian/ 
Alaska Native 
4 3   
Asian 15 21   
Native Hawaiian/ 
Pacific Islander 
1 2   
Black/ African 
American 
18 38   
White 133 108   
Ethnicity   X
2
= 3.44 0.063 
Hispanic/Latino 27 36   
Not Hispanic/Latino 144 136   
SZ =schizophrenia; M =Male; F =Female; L =Left handed; R =Right handed; A =Ambidextrous; 
*p<0.05 
 
3.22 Symptom and Cognitive Measures: 
Symptom severities were assessed using the SANS [10-12] which was administered as 
part of the Structured Clinical Interview which was used to confirm diagnosis.  Overall, the 
SANS has been demonstrated to have very good reliability, with moderate reliability for the 
individual domain scores [10-12]. IQ was measured using the North American Adult Reading 
Test. 
3.23 Resting-State Imaging:  
Resting-state imaging was performed while participants were lying on their backs in the 
scanner with their eyes open. Participants were asked to focus on a fixation cross presented to 
them via a mirror while in the scanner bore.  
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Table 7 
Comparison of negative symptom scores in study 2 by showing means, standard deviations, and correlation values. 
Symptom Flat 
Affect 
M=5.67 
SD=6.57 
 
Alogia 
M=2.13 
SD=2.97 
 
Avolition/ 
Apathy 
M =4.71 
SD =3.36 
 
Anhedonia/ 
Asociality 
M =6.88 
SD =5.06 
 
Avolition 
Factor  
M=11.59 
SD=7.08 
 
Expression 
Factor 
M=7.81 
SD=8.66 
 
Total Negative 
M =19.41 
SD =13.04 
0.85* 0.64* 0.75* 0.90* 0.86* -0.03 
Flat Affect  0.59* 0.31* 0.33* 0.38* 0.96* 
Alogia   0.28* 0.10 0.21* 0.79* 
Avolition/Apathy    0.61* 0.31* 3.53E-05 
Anhedonia/Asociality     0.28* -0.05 
Avolition Factor      -0.03 
df = 170, * p<0.05  
 
3.24 Imaging Parameters 
Imaging parameters were standardized between all sites on 3 Tesla MRI scanners. 
Structural images were acquired using a sagittal plane MP-Rage pulse sequence (TR = 2300 ms, 
TE = 2.94ms, matrix = 256 x192, FOV = 22cm, slices = 160 (interleaved), thickness = 1.2mm). 
Functional resting-state scans were acquired using an ep2d_pace pulse sequence on the oblique 
axial plane aligned to the AC-PC line (TR = 2000ms, TE = 30ms, Flip Angle = 77, matrix = 64 x 
64, FOV = 22cm, slices = 32 (sequential), thickness = 4mm, gap = 1mm). 
3.25 Image Processing 
Image data was processed using the Brain Imaging and Analysis Center (BIAC) resting 
state pipeline, which relies on functions from the FMRIB Software Library (FSL, 
www.fmrib.ox.ac.uk/fsl) [115-117]. Images were corrected for slice timing, motion, and b0 field 
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irregularities. Brain extraction was carried out using FSL and 8mm full-width at half maximum 
Gaussian smoothing was carried out using Freesurfer so that images from all sites were 
consistently smooth. Image data then underwent band-pass filtering and was parcellated using 
the Automated Anatomical Labeling (AAL) atlas into a set of 116 regions. Finally, inter-regional 
functional connections were calculated, accounting for physiological measures including heart 
rate and respiration rate, and a 116 x 116 region correlation matrix was generated. For the 
purposes of this study, cerebellar and brain stem regions were excluded, leaving a 90 region x 90 
region matrix.   
3.26 Statistical Analysis 
Contrasts and correlations were carried out using a general linear model (GLM) using 
FSL's randomize function. A degree-based multiple comparisons correction was carried out. 
Briefly, a Monte Carlo simulation was carried out for 10,000 iterations in order to determine the 
probability of n false positives in a given column of the matrix. The likelihood of 12 or more 
significant connections within the same column of a 90x90 matrix was <0.05. Connections with 
p < 0.05 within these columns were retained. 
All participants were contrasted based on clinical category (HC vs. SCZ). The 
relationship between negative symptoms and functional connectivity was assessed in 
schizophrenia patients  based on their severity of total negative symptoms, severity of individual 
negative symptom domains (flat affect, avolition/apathy, anhedonia/asociality, alogia), and based 
on severity of negative symptom factors (Avolition and Emotional Expression). Contrasts were 
carried out between patients with ‘high’ and ‘low’ symptom severities. For each symptom 
variable, the median severity was used to divide patients into the ‘high’ and ‘low’ categories.  
Correlation analyses were carried out similarly for total negative symptoms, individual symptom 
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domains, and for the two factor division of negative symptoms in three separate models. Age, 
gender, imaging site, and chlorpromazine equivalent drug dosages [141] were used as covariates 
in these analyses. Overall, 7 models were tested; patients vs. controls, total negative symptoms 
correlation, total negative symptoms high vs. low, negative symptom domain correlations, 
negative symptom domain high vs. low, 2-factor model correlation, and 2-factor model high vs. 
low. In the symptom domain models, all 4 domains were included such that each symptom 
domain was used as a covariate for the analysis of every other symptom domain. For instance, 
when analyzing flat affect, alogia, anhedonia/asociality, and avolition/apathy were included in 
the same model as covariates. The expression and avolition factors were handled similarly in the 
2-factor models.  
The identified networks were further analyzed using a Louvain detection algorithm in 
order to identify networks within the results based on relative levels of community [142].  
3.3 Results 
Resting-state functional connectivity differences between patients and healthy controls 
An extensive set of connections were found to differ between schizophrenia patients and 
healthy controls (Figure 5). The key to the numeric labels used for all of the resting-state figures 
is found in Table 8. We used a Louvain detection algorithm to separate the significant 
connections into networks based on their degree of community [142].  
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Figure 5 Correlation matrices showing functional connectivity contrast between patients and healthy controls with A) healthy 
controls showing greater connectivity than patients and B) healthy controls showing less connectivity than patients.Significant 
connections are shown in white. Axes are numerically labeled to represent the 90 regions of the AAL atlas (Table 8). 
 
We found four such networks where schizophrenia patients showed decreased functional 
connectivity compared against healthy controls (Figure 6a). These included a network comprised 
of medial prefrontal, superior temporal, cingulate, lateral parietal, and inferior occipital regions 
as well as insula, caudate, and hippocampus; a network comprised of frontal and parietal regions; 
a network comprised of middle cingulate, insula, parietal, occipital, and superior temporal 
regions; and a network comprised of inferior and lateral parietal cortex, superior temporal cortex, 
inferior prefrontal cortex, middle cingulate, and occipital cortex.  
Schizophrenia patients exhibited increased connectivity in 3 networks (Figure 6b). The 
first consisted of thalamus, middle and superior temporal regions, superior parietal cortex, 
occipital regions, and the fusiform gyrus; the second consisted of portions of the striatum, 
inferior prefrontal cortex, orbital prefrontal cortex, thalamus, medial temporal cortex, and lateral 
parietal cortex; and the third consisted of superior occipital cortex, medial temporal cortex, 
striatal regions, and orbital prefrontal cortex.  
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Table 8 
Numeric key to AAL atlas regions used in resting-state analysis 
Region Left Right Region Left Right 
Precentral g. 1 2 Lingual g. 47 48 
Sup Frontal g. 3 4 Sup Occipital g. 49 50 
Orb Sup Frontal g. 5 6 Mid Occipital g. 51 52 
Mid Frontal g. 7 8 Inf Occipital g. 53 54 
Orb Mid Frontal g. 9 10 Fusiform g. 55 56 
Oper Inf Frontal g. 11 12 Postcentral g. 57 58 
Tri Inf Frontal g. 13 14 Sup Parietal g. 59 60 
Orb Inf Frontal g. 15 16 Inf Parietal g. 61 62 
Rolandic Oper 17 18 Supramarginal g. 63 64 
Supp Motor Area 19 20 Angular g. 65 66 
Olfactory 21 22 Precuneus 67 68 
Medial Sup Frontal g. 23 24 Paracentral lobule 69 70 
Orb Med Frontal g. 25 26 Caudate 71 72 
Rectus 27 28 Putamen 73 74 
Insula 29 30 Pallidum 75 76 
Ant Cingulum 31 32 Thalamus 77 78 
Mid Cingulum 33 34 Heschl 79 80 
Post Cingulum 35 36 Sup Temporal g. 81 82 
Hippocampus 37 38 Sup Temporal Pole 83 84 
Parahippocampal g. 39 40 Mid Temporal g. 85 86 
Amygdala 41 42 Mid Temporal Pole 87 88 
Calcarine 43 44 Inf Temporal g. 89 90 
Cuneus 45 46    
      
Clinical Symptoms 
Total negative symptom score was significantly correlated with the score for each 
individual item and with the Avolition factor, but was not significantly correlated with the 
Expression Factor (see Table 7). Flat affect was significantly correlated with alogia, 
avolition/apathy, and anhedonia/asociality as well as the Avolition factor and Expression factor. 
Alogia was correlated with every other symptom measure except anhedonia/asociality. Neither 
avolition/apathy nor anhedonia/asociality were significantly correlated with the Expression 
factor, but were significantly correlated with the other symptom measures. The Avolition factor 
was not significantly correlated with the Expression factor.  
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Figure 6 Connectivity graphs showing functional connectivity differences between patients and healthy controls with A) 
showing areas where patients had greater connectivity and B) showing areas where patients had less connectivity than healthy 
controls. . Nodes are spatially located with reference to their position on a 2-d anatomical overlay (Figure 7). Only significant 
edges and nodes with significant edges are shown (p<0.05). Color information denotes sub-networks identified using Louvain 
algorithm. Node size indicates degree (number of significant connections) Nodes are numerically labeled to represent the 90 
regions of the AAL atlas (Table 8). 
 
 
 
Figure 7 Two-dimensional key to connectivity graphs showing the spatial location of AAL atlas regions (Table 8). 
Correlation between resting-state functional connectivity and negative symptoms 
Total Negative Symptoms 
The severity of total negative symptoms was correlated with several functional 
connections in the brain (Figure 6a, Table 9). A Louvain detection algorithm was used to group 
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these connections into networks based on their degree of community. Four networks were 
identified (Figure 8a); an anterior network comprised mainly of inferior and medial portions of 
the prefrontal cortex, a posterior network comprised mainly of occipital cortex regions, and two 
separate networks that included primarily cingulate and parietal regions. These two networks 
were differentiated by hemisphere, with one being found primarily on the right, while the other 
was found primarily on the left. 
Individual Negative Symptoms 
Functional connectivity was significantly correlated with severity of flat affect, alogia, 
and anhedonia/asociality (Figure 9b-d, Table 9), but there were no significant correlations 
between avolition/apathy and resting-state connectivity. We identified sub-networks for each 
symptom category by calculating their degree of community using the same Louvain algorithm 
mentioned above. These connectivity matrices were overlain with the connectivity matrix for 
total negative symptoms in Figure 10 in order to show similarities and differences between the 
connectivity associated with total symptoms and individual domains. 
We found that Flatness of Affect was associated with six networks (Figure 8b). The first 
was comprised of middle cingulate, parietal, and occipital regions; the second was comprised of 
posterior cingulate, medial orbital frontal, precuneus, and post-central gyrus; the third was 
comprised of the insula, superior temporal, supramarginal gyrus, and medial orbital prefrontal 
cortex; the fourth was comprised of the thalamus, putamen, posterior cingulate, and precuneus; 
the fifth consisted of connections between medial orbital prefrontal cortex, caudate, thalamus, 
posterior cingulate, temporal cortex, and occipital cortex; and the sixth consisted of connections 
between medial orbital prefrontal cortex, medial temporal areas, posterior cingulate, thalamus, 
and precuneus. 
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Figure 8 Connectivity graphs showing correlation between negative symptoms and functional connectivity for A) total negative 
symptoms B) flat affect C) alogia D) anhedonia/asociality E) avolition factor F) expression factor. Nodes are spatially located 
with reference to their position on a 2-d anatomical overlay (Figure 7). Only significant edges and nodes with significant edges 
are shown (p<0.05). Color information denotes sub-networks identified using Louvain algorithm. Node size indicates degree 
(number of significant connections) Nodes are numerically labeled to represent the 90 regions of the AAL atlas (Table 8). 
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Table 9 
Listing of functional connections showing a significant correlation with negative symptoms 
Total Negative Symptoms 
R rolandic operculum 
 R insula 
 Bi postcentral g. 
 Bi inf parietal g. 
 Bi supramarginal g. 
 R paracentral lobule 
 Bi sup temporal g. 
 R olfactory cortex 
 Bi orb med frontal g. 
 Bi ant cingulate 
 Bi post cingulate 
 L hippocampus 
 R parahippocampus 
 R amygdala 
 R angular g. 
 Bi caudate 
 L med sup frontal g. 
 R med sup frontal g. 
 L ant cingulate 
 Bi post cingulate 
 Bi angular g. 
 L putamen 
 Bi pallidum 
 L orb med frontal g. 
 R orb med frontal g. 
 Bi rectus 
 R ant cingulate 
 L post cingulate 
 L hippocampus 
 R amygdala 
 L fusiform g. 
 R caudate 
 R mid temporal pole 
 R insula 
 R mid cingulate 
 Bi inf parietal g. 
 Bi supramarginal g. 
 Bi sup temporal g. 
 R sup temporal pole 
 R ant cingulate 
 Bi mid cingulate 
 Bi post cingulate 
 R parahippocampus 
 R amygdala 
 Bi caudate 
 Bi thalamus 
L mid cingulate 
 R mid cingulate 
 L post cingulate 
 R cuneus 
 Bi postcentral g. 
 Bi inf parietal g. 
 Bi supramarginal g. 
 Bi precuneus 
 R paracentral lobule 
 L heschls g. 
L post cingulate 
 R post cingulate 
 L cuneus 
 Bi angular g. 
 Bi precuneus 
 L mid temporal g. 
R mid cingulate 
 Bi post cingulate 
 Bi postcentral g. 
 R inf parietal g. 
 L supramarginal g. 
 R angular g. 
 R precuneus 
 R paracentral lobule 
 R putamen 
 R post cingulate 
 L cuneus 
 R angular g. 
 Bi precuneus 
 R paracentral lobule 
 L cuneus 
 R cuneus 
 Bi lingual g. 
 Bi sup occipital g. 
 Bi mid occipital g. 
 Bi precuneus 
 R postcentral g. 
 Bi supramarginal g. 
 L paracentral lobule 
 Bi heschls g. 
 R sup temporal g. 
 L inf parietal g. 
 R inf parietal g. 
 Bi putamen 
 R sup temporal pole 
R inf parietal g. 
 R supramarginal g. 
 R putamen 
 L heschls g. 
 R sup temporal pole 
 L supramarginal g. 
 R supramarginal g. 
 Bi sup temporal g. 
 R sup temporal pole 
 R supramarginal g. 
 L heschls g. 
 L sup temporal g. 
 R sup temporal pole 
 L heschls g. 
 R heschls g. 
 Bi sup temporal g. 
 R sup temporal pole 
 R mid temporal g. 
Flat Affect 
 L orb med frontal g. 
 R orb med frontal g. 
 R insula 
 Bi post cingulate 
 R cuneus 
 Bi mid occipital g. 
 R caudate 
 Bi thalamus 
 L heschls g. 
 R sup temporal g. 
 R mid temporal g. 
L insula 
 R insula 
 Bi supramarginal g. 
 R heschls g. 
 Bi sup temporal g. 
R orb med frontal g. 
 L insula 
 Bi post cingulate 
 L hippocampus 
 L cuneus 
 R mid occipital g. 
 Bi precuneus 
 R paracentral lobule 
 Bi thalamus 
 L heschls g. 
  L mid cingulate 
 R mid cingulate 
 R cuneus 
 Bi inf parietal g. 
 Bi supramarginal g. 
 R angular g. 
 R precuneus 
 L post cingulate 
 Bi postcentral g. 
 Bi precuneus 
 R paracentral lobule 
 R post cingulate 
 L postcentral g. 
 Bi precuneus 
 Bi paracentral lobule 
 L supramarginal g. 
 R supramarginal g. 
 Bi heschls g. 
 R sup temporal g. 
 R sup temporal pole 
 R mid temporal pole 
R precuneus 
 Bi putamen 
 R thalamus 
Alogia 
 R hippocampus 
 Bi parahippocampus 
 R fusiform g. 
 R paracentral lobule 
 R mid temporal pole 
 R parahippocampus 
 R fusiform g. 
 Bi mid temporal pole 
 L supramarginal g. 
 Bi caudate 
 L mid temporal pole 
 R mid temporal pole 
 Bi mid temporal g. 
Anhedonia/Asociality 
R precentral g. 
 L rolandic operculum 
 Bi calcarine cortex 
 L cuneus 
 L sup occipital g. 
 L mid occipital g. 
 L inf occipital g. 
 Bi postcentral g. 
 R sup parietal g. 
 L inf parietal g. 
 L supramarginal g. 
 
R olfactory cortex 
 R orb med frontal g. 
 L ant cingulate 
 R mid cingulate 
 Bi post cingulate 
 L hippocampus 
 R caudate 
 Bi putamen 
 R pallidum 
 Bi thalamus 
 L post cingulate 
 Bi parahippocampus 
 R pallidum 
 L sup temporal pole 
 L mid temporal g. 
 R mid temporal pole 
 R inf temporal g. 
 R parahippocampus 
 Bi caudate 
 L thalamus 
 R heschls g. 
 R sup temporal g. 
 R cuneus 
 L lingual g. 
 Bi sup occipital g. 
 R mid occipital g. 
 Bi inf occipital g. 
 L postcentral g. 
 Bi sup parietal g. 
 R precuneus 
 R sup occipital g. 
 R mid occipital g. 
 Bi inf occipital g. 
 L postcentral g. 
 R sup parietal g. 
 L inf parietal g. 
 R precuneus 
 R mid occipital g. 
 Bi inf occipital g. 
 R fusiform g. 
 R sup parietal g. 
 R precuneus 
 R sup parietal g. 
 L inf parietal g. 
 Bi supramarginal g. 
 R precuneus 
 L heschls g. 
 R sup temporal g. 
 R pallidum 
 Bi thalamus 
 L mid temporal g. 
 L thalamus 
 L sup temporal pole 
 R thalamus 
 L inf temporal g. 
 L heschls g. 
 R heschls g. 
 Bi sup temporal g. 
 R sup temporal pole 
 L sup temporal g. 
 R sup temporal g. 
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We found that Alogia was associated with three networks (Figure 8c). These included a 
set of connections between bilateral caudate and left supramarginal gyrus; a set of connections 
between the temporal poles, and right medial temporal cortex regions (hippocampus and 
parahippocampus); and a set of connections between medial temporal cortex, medial parietal 
cortex, the right temporal pole, and the fusiform gyrus.  
We found that Anhedonia/Asociality was associated with 4 networks (Figure 8d). These 
consisted of an occipital-parietal network; a network consisting of the posterior cingulate, 
pallidum, and temporal regions; a network consisting of inferior parietal, medial occipital, and 
superior temporal cortex; and a network consisting of posterior cingulate, thalamus, caudate, 
parahippocampus, and superior temporal regions. 
Two-Factor Model 
We also tested whether a two-factor model as proposed for DSM-V was significantly correlated 
with functional activity. We tested an Avolition Factor (AA) which we calculated by combining 
the Avolition/Apathy and Anhedonia/Asociality domains and an Expression Factor (EE) which 
we calculated by combining the Flat Affect and Alogia domains. Regions showing symptom-
correlated connectivity are listed in Table 11. For each of these categories, we identified several 
connections that were significantly associated with each of these factors (Figure 9e, f) and so we 
used a Louvain algorithm to identify subnetworks within these connections. For the Avolition 
Factor we identified two sub-networks (Figure 8e). The first was centered on the left inferior 
occipital cortex and the second was centered on the right cuneus. We identified four sub-
networks that were associated with the Expression Factor (Figure 8f). These included a bilateral 
network consisting of the putamen and middle cingulate; a network consisting of the insula, 
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temporal, and parietal regions; a network consisting of cingulate, temporal, and parietal regions; 
and a network consisting of cingulate, parietal, and occipital regions.   
Contrasts of resting-state connectivity between ‘high’ and ‘low’ symptom severity 
We separately analyzed the resting-state functional connectivity data using contrasts 
between patients experiencing ‘high’ and ‘low’ symptom severity. For each symptom category 
(total negative, individual symptoms, and the two-factor model), we divided patients into two 
groups based on whether they experience more or less severe symptoms than the median of that 
symptom category. Significant connections were then grouped using a Louvain detection 
algorithm into subnetworks for each symptom category. 
Total Negative Symptoms 
There were no regions where connectivity was decreased in ‘high’ symptom severity patients. 
However, the ‘high’ severity group had increased functional connectivity within two networks 
compared to the ‘low’ severity group (Figure 11a, Figure 12a, and Table 10). These networks 
included one centered on the amygdala that included inferior and ventral parietal areas, temporal 
regions, and occipital regions. The other network was small and consisted of only one edge 
between the left fusiform and left superior parietal gyrus.  
Individual Negative Symptoms 
For Flat Affect, increased connectivity was present for the ‘high’ group compared to the 
‘low’ group within two networks (Figure13a, Figure 15a, and Table 10). These included a 
network consisting of the posterior cingulate, precuneus, superior parietal cortex, and middle 
occipital cortex as well as a network consisting of inferior and middle occipital cortex and left 
pallidum. 
52 
 
 
Figure 9 Correlation matrices showing correlation between negative symptoms and functional connectivity for A) total negative 
symptoms B) flat affect C) alogia D) anhedonia/asociality E) expression factor F) avolition factor. Significant connections are 
shown in white. Axes are numerically labeled to represent the 90 regions of the AAL atlas (Table 8). 
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Figure 10 Overlay of Symptom domain connectivity matrices with the connectivity matrix for total negative symptoms in the 
correlation analysis. White squares are connections that are present in both the individual symptom domain and the total negative 
symptom contrast, light grey squares are connections that are only present in the total negative symptoms contrast, dark grey 
squares are areas that are not connected in either contrast, and black squares are connections that are present in only the 
individual symptom domain contrast. Matrix overlays are shown for A) Flat affect, B) Alogia, C) Anhedonia/Asociality. 
 
Decreased connectivity was present for the ‘high’ group compared to the ‘low’ group within four 
networks (Figure 13b, Figure 15b). These included a network centered around the left orbital 
middle frontal gyrus that included mainly parietal regions; a network centered around the right 
superior frontal gyrus that consisted of inferior prefrontal regions, superior temporal cortex, 
lateral parietal cortex, and occipital regions; a network focused on the left middle occipital gyrus 
with connections to lateral parietal regions, and a network centered around the right superior 
occipital gyrus with connections to lateral parietal regions and to the caudate.  
The ‘high’ severity group for alogia showed significantly increased connectivity in three 
networks and decreased connectivity in one network compared with the ‘low’ severity group 
(Figure 13c, Figure 15c, and Table 10). Connectivity was increased in a network centered on the 
right superior frontal gyrus that included orbital frontal, inferior temporal, hippocampal, 
parahippocampal, and middle cingulate cortex along with the pallidum and thalamus. 
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Figure 11 Connectivity graphs showing functional connectivity contrasts between A) total negative symptoms B) avolition factor 
and C) expression factor high vs. low. Nodes are spatially located with reference to their position on a 2-d anatomical overlay 
(Figure 7). Only significant edges and nodes with significant edges are shown (p<0.05). Color information denotes sub-networks 
identified using Louvain algorithm. Node size indicates degree (number of significant connections) Nodes are numerically 
labeled to represent the 90 regions of the AAL atlas (Table 8). 
Connectivity was also increased in a network centered on the left parahippocampus that 
included frontal, temporal, and parietal cortex regions. Connectivity was increased in a third 
network that included the right superior temporal gyrus, the left middle temporal gyrus, and the 
thalamus. Connectivity was decreased in a network centered on the amygdala that included the 
right putamen, precuneus, and occipital cortex regions (Figure 15a).  
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Individuals with ‘high’ severity avolition/apathy were found to have increased connectivity 
within 4 networks (Figure 13e, Figure 15e, and Table 10) and decreased connectivity within 5 
networks (Figure 13f, Figure 15f).  
Increased connectivity was found in a network centered around the right putamen that 
included bilateral temporal cortex regions; in a network centered around the right fusiform gyrus 
that included portions of the striatum and thalamus along with left orbital frontal cortex and 
bilateral superior temporal cortex; in a network centered around the left orbital frontal cortex that 
included bilateral lateral parietal cortex regions; and in a network centered around bilateral 
inferior orbital frontal cortex that included inferior and medial prefrontal cortex and ventral 
temporal, parietal, and occipital cortex regions. Decreased connectivity was found in a network 
consisting of inferior and ventral frontal cortex, temporal pole, parahippocampus, and caudate 
nucleus; in a network consisting of the thalamus, the amygdala, ventral frontal, hippocampus, 
parahippocampus, and fusiform gyrus; in a network consisting of right fusiform, middle 
cingulate, precuneus, superior parietal cortex and inferior frontal cortex; in a network consisting 
of primarily temporal regions and right fusiform gyrus; and in an extensive network consisting of 
middle cingulate, parahippocampus, insula, temporal cortex regions, and lateral parietal cortex. 
The ‘high’ severity group for anhedonia/asociality was associated with increased connectivity in 
4 networks (Figure 12d, Figure 15g, and Table 10) and decreased connectivity in 5 networks 
(Figure 12e, Figure 15h).  
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Figure 12 Correlation matrices showing functional connectivity contrast between negative symptoms high vs. low 
for A) total negative symptoms B) avolition factor C) expression factor D & E) anhedonia/asociality. Significant 
connections are shown in white. Axes are numerically labeled to represent the 90 regions of the AAL atlas (Table 8). 
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Figure 13 Correlation matrices showing functional connectivity contrast between negative symptom domains high vs. low for A 
& B) flat affect C&D) alogia E&F) avolition/apathy. Significant connections are shown in white. Axes are numerically labeled to 
represent the 90 regions of the AAL atlas (Table 8). 
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Connectivity was  increased in a network centered on the right middle cingulate and consisting 
of amygdala, temporal cortex, hippocampus, parahippocampus, and inferior occipital cortex; in a 
network centered on the parahippocampus that included the caudate, middle and posterior 
cingulate, and cuneus; in a network centered on the left posterior cingulate that included middle 
and inferior temporal cortex, parahippocampus, amygdala, pallidum, and temporal pole; and in a 
network centered on the right inferior occipital cortex that included superior parietal cortex, 
fusiform gyrus, temporal pole, supramarginal gyrus, and inferior parietal cortex.  
Connectivity was decreased in the ‘high’ severity group in a network centered on the 
inferior orbital frontal cortex that included superior temporal cortex, superior parietal cortex, and 
inferior occipital cortex; in a network centered on the anterior cingulate that included superior 
temporal cortex, supramarginal gyrus, and right middle and inferior occipital cortex; in a 
network centered on the right inferior occipital cortex that included the thalamus, caudate, 
anterior cingulate, temporal pole, and orbital region of the superior frontal gyrus; in a network 
centered on the right fusiform gyrus that included temporal cortex regions; and in a network 
centered on the left insula that included middle temporal gyrus, fusiform, and inferior and middle 
occipital cortex. 
The connectivity matrices for each symptom domain were overlain with the connectivity 
matrix for total negative symptoms in Figure 14 in order to show similarities and differences 
between the connectivity associated with total symptoms and individual domains. 
Two-Factor Model 
Connectivity was not significantly increased in the ‘high’ group for either the avolition 
factor (AA) or the expression factor (EE). However, decreased connectivity was found in the 
‘high’ group compared to the ‘low’ group for AA within two networks (Figure 11b, Figure 12b, 
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and Table 11). One of these was centered on the right hippocampus and included caudate, right 
middle temporal gyrus, inferior occipital cortex, left fusiform gyrus, and right lingual gyrus. The 
other included the left superior temporal gyrus and the temporal poles. Decreased connectivity in 
the ‘high’ group compared to the low group was also found in one network for EE (Figure 11c, 
Figure 12c, and Table 11). This network consisted of connections between the left middle 
occipital gyrus and parietal regions. 
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Table 10 
Listing of functional connections associated with increased (High > Low) and decreased (High < Low) 
connectivity in high severity group. 
High > Low High > Low High < Low High < Low High < Low 
Total Negative Symptoms 
 L amygdala 
 Bi cuneus 
 R sup occipital 
 Bi fusiform 
 R inf parietal 
 Bi sup temp pole 
 L mid temp pole 
 L inf temporal 
 L fusiform 
 L sup parietal 
Anhedonia/Asociality 
R mid cingulate 
 Bi hippocampus 
 R parahippocampus 
 R amygdala 
 Bi inf occipital 
 L heschls 
 L sup temporal 
 L mid temporal 
 L inf temporal 
 L post cingulate 
 Bi parahippocampus 
 L amygdala 
 R pallidum 
 Bi sup temp pole 
 L mid temporal 
 R mid temp pole 
 R inf temporal 
 R parahippocampus 
 L cuneus 
 R caudate 
 R sup occipital 
 Bi inf occipital 
 R fusiform 
 R sup parietal 
 L inf parietal 
 L supramarginal 
 R sup temp pole 
 Bi mid temp pole 
Alogia 
 R sup frontal 
 L orb sup frontal 
 Bi orb med frontal 
 Bi rectus 
 R mid cingulate 
 L hippocampus 
 L parahippocampus 
 Bi pallidum 
 Bi thalamus 
 L sup temp pole 
 Bi mid temporal 
 L parahippocampus 
 R parahippocampus 
 L sup parietal 
 R inf parietal 
 R angular 
 Bi sup temp pole 
 Bi mid temp pole 
 L thalamus 
 L mid temporal 
 
 
Avolition/Apathy 
 L orb sup frontal 
 R mid frontal 
 R orb mid frontal 
 R tri inf frontal 
 Bi orb inf frontal 
 R postcentral 
 R sup parietal 
 R inf parietal 
 R supramarginal 
 R heschls 
 R mid temporal 
 R inf temporal 
 L orb mid frontal 
 R tri inf frontal 
 R mid cingulate 
 L sup occipital 
 R fusiform 
 Bi postcentral 
 R sup parietal 
 R inf parietal 
 R supramarginal 
 R angular 
 L orb inf frontal 
 R orb med frontal 
 Bi rectus 
 L calcarine cortex 
 Bi fusiform 
 R sup parietal 
 R inf temporal 
 R orb inf frontal 
 Bi rectus 
 Bi parahippocampus 
 L calcarine cortex 
 R lingual 
 R inf occipital 
 Bi fusiform 
 R mid temp pole 
 R fusiform 
 Bi caudate 
 Bi putamen 
 Bi pallidum 
 L thalamus 
 Bi sup temp pole 
 R mid temp pole 
 Bi mid temporal 
 R putamen 
 Bi heschls 
 Bi sup temporal 
 R mid temporal 
 R mid temp pole 
 L sup temp pole 
 R inf temporal 
Flat Affect 
R post cingulate 
 R mid occipital 
 Bi postcentral 
 R sup parietal 
 Bi precuneus 
 R paracentral lobule 
 L mid occipital 
 Bi inf occipital 
 L pallidum 
 R sup temp pole 
 
Avolition/Apathy 
 L oper inf frontal 
 Bi orb inf frontal 
 Bi olfactory cortex 
 L rectus 
 Bi parahippocampus 
 R caudate 
 Bi sup temp pole 
 L inf temporal 
 L rolandic operculum 
 R rolandic operculum 
 R insula 
 R mid cingulate 
 L parahippocampus 
 R inf occipital 
 R fusiform 
 Bi postcentral 
 Bi inf parietal 
 Bi supramarginal 
 Bi heschls 
 R sup temporal 
 Bi sup temp pole 
 R mid temporal 
 R mid temp pole 
 R inf temporal 
 R olfactory cortex 
 Bi med sup frontal 
 L ant cingulate 
 Bi mid cingulate 
 L supramarginal 
 L angular 
 Bi thalamus 
 L insula 
 R insula 
 R mid cingulate 
 R postcentral 
 R inf parietal 
 R supramarginal 
 R heschls 
 R sup temporal 
 Bi sup temp pole 
 L mid cingulate 
 Bi parahippocampus 
 Bi amygdala 
 Bi fusiform 
 L thalamus 
 L sup temp pole 
 L mid temp pole 
 L inf temporal 
 L post cingulate 
 L amygdala 
 R paracentral lobule 
 L sup temp pole 
 R hippocampus 
 R inf parietal 
 R angular 
 Bi caudate 
 L parahippocampus 
 L supramarginal 
 Bi precuneus 
 L sup temporal 
L supramarginal 
 R heschls 
 Bi mid temp pole 
R parahippocampus 
 L mid occipital 
 L supramarginal 
 L angular 
 L precuneus 
 R amygdala 
 L inf parietal 
 L supramarginal 
 L angular 
 L sup temporal 
 R fusiform 
 Bi postcentral 
 Bi sup parietal 
 L precuneus 
 Bi paracentral lobule 
 L heschls 
 L sup temporal 
 R thalamus 
 L mid temporal 
 L heschls 
 R heschls 
 Bi sup temporal 
 Bi sup temp pole 
 Bi mid temp pole 
 R inf temporal 
 L sup temporal 
 R sup temporal 
 Bi sup temp pole 
 R mid temp pole 
 R sup temporal 
 R sup temp pole 
 L mid temporal 
 R mid temp pole 
 L sup temp pole 
 L mid temporal 
Flat Affect 
 R sup frontal 
 L orb inf frontal 
 L rectus 
 Bi sup occipital 
 L mid occipital 
 L sup parietal 
 L inf parietal 
 Bi supramarginal 
 L sup temporal 
 Bi sup temp pole 
 L mid temp pole 
 L inf temporal 
 L orb mid frontal 
 R oper inf frontal 
 Bi supplementary motor 
area 
 Bi postcentral 
 Bi sup parietal 
 Bi inf parietal 
 L supramarginal 
 L paracentral lobule 
 L sup occipital 
 R angular 
 R caudate 
 R sup occipital 
 Bi inf parietal 
 Bi angular 
 Bi caudate 
 
L mid occipital 
 L sup parietal 
 Bi inf parietal 
 L supramarginal 
 Bi angular 
Alogia 
 R amygdala 
 Bi calcarine 
cortex 
 R cuneus 
 Bi lingual 
 Bi sup occipital 
 L mid occipital 
 L inf occipital 
 R fusiform 
 Bi precuneus 
Anhedonia/Asociality 
 L orb sup frontal 
 R mid frontal 
 L olfactory cortex 
 Bi inf occipital 
 R postcentral 
 R sup parietal 
 R supramarginal 
 Bi sup temporal 
 Bi mid temporal 
 R inf temporal 
 L insula 
 R lingual 
 L mid occipital 
 Bi inf occipital 
 Bi fusiform 
 L mid temporal 
 Bi mid temp pole 
 L ant cingulate 
 R mid occipital 
 R inf occipital 
 Bi supramarginal 
 R heschls 
 L sup temporal 
 R ant cingulate 
 L sup parietal 
 Bi inf parietal 
 Bi supramarginal 
 R heschls 
 R sup temporal 
 R inf occipital 
 L caudate 
 Bi thalamus 
 L sup temp pole 
 R pallidum 
 R sup temporal 
 R sup temp pole 
 Bi mid temp pole 
 R inf temporal 
 L sup temporal 
 L mid temporal 
 R sup temp pole 
 Bi mid temporal 
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Figure 14 Overlay of Symptom domain connectivity matrices with the connectivity matrix for total negative symptoms in the 
high > low symptom severity contrast. White squares are connections that are present in both the individual symptom domain and 
the total negative symptom contrast, light grey squares are connections that are only present in the total negative symptoms 
contrast, dark grey squares are areas that are not connected in either contrast, and black squares are connections that are present 
in only the individual symptom domain contrast. Matrix overlays are shown for A) Flat affect, B) Alogia, C) Avolition/Apathy, 
and D) Anhedonia/Asociality. 
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Figure 15 Connectivity graphs showing functional connectivity contrasts between negative symptom domains high 
vs. low A&B) Flat affect C&D) alogia E&F) avolition/apathy G&H) anhedonia asociality. Nodes are spatially 
located with reference to their position on a 2-d anatomical overlay. Only significant edges and nodes with 
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Table 11 
Listing of connections positively correlated with avolition and expression factors as well as connections 
showing decreased (High < Low) connectivity in high severity groups. 
Correlation with  
Expression Factor 
A positive correlation between the severity 
of the expression factor was found 
between  
L rolandic operculum 
 R rolandic operculum 
 R orb med frontal 
 R rectus 
 Bi insula 
 L parahippocampal 
 Bi postcentral 
 R supramarginal 
 Bi heschls 
 Bi sup temporal 
 R sup temporal pole 
 L supplementary motor area 
 R supplementary motor area 
 L ant cingulate 
 Bi mid cingulate 
 Bi postcentral 
 L inf parietal 
 Bi supramarginal 
 R thalamus 
 L heschls 
 R supplementary motor area 
 Bi mid cingulate 
 Bi post cingulate 
 R fusiform 
 R postcentral 
 Bi supramarginal 
 L pallidum 
 R thalamus 
 L heschls 
 
 
L insula 
 R insula 
 L parahippocampal 
 L postcentral 
 Bi supramarginal 
 R sup temporal 
 Bi sup temporal pole 
 L mid cingulate 
 R mid cingulate 
 Bi post cingulate 
 R cuneus 
 R inf parietal 
 R angular 
 R precuneus 
 Bi putamen 
 R mid cingulate 
 Bi post cingulate 
 L postcentral 
 R angular 
 L putamen 
 L post cingulate 
 R post cingulate 
 Bi angular 
 Bi precuneus 
 R paracentral lobule 
R post cingulate 
 Bi cuneus 
 R mid occipital 
 Bi angular 
 Bi precuneus 
 R paracentral lobule 
 L putamen 
 R putamen 
 R putamen 
 L pallidum 
 L heschls 
 Bi sup temporal 
 
Correlation with  
Avolition Factor 
A positive correlation between the severity of 
the avolition factor was found between  
R cuneus 
 Bi lingual 
 Bi sup occipital 
 R mid occipital 
 Bi inf occipital 
 L fusiform, 
 R sup parietal; 
 between L inf occipital 
 R inf occipital 
 L postcentral 
 Bi sup parietal 
 L inf parietal, 
 Bi supramarginal. 
Avolition Factor High < Low 
 R hippocampus 
 R lingual 
 Bi inf occipital 
 L fusiform 
 Bi caudate 
 R mid temporal 
 L sup temporal 
 L sup temporal pole 
 Bi mid temporal pole 
Expression Factor High < Low 
 L mid occipital g. 
 Bi postcentral g. 
 Bi sup parietal g. 
 R inf parietal g. 
 Bi supramarginal g. 
 R angular g. 
 R precuneus 
 
Significant edges are shown (p<0.05). Color information denotes sub-networks identified using Louvain algorithm. 
Node size indicates degree (number of significant connections) Nodes are numerically labeled to represent the 90 
regions of the AAL atlas (Table 8).
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3.4 Discussion 
3.4.1 Overview 
 Our primary goal for conducting this research was to explore the relationship between the 
negative symptoms of schizophrenia and functional connectivity within the brain. We found that 
functional connectivity of DMN, limbic system, and SN were correlated with overall negative 
symptom severity and that there were significant differences in functional connectivity between 
patients with high and low levels of total negative symptoms. Importantly, we also found that 
these relationships were present when the negative symptoms were divided into their constitutive 
domains and when negative symptoms were divided into a two-factor model that is consistent 
with the clinical grouping that is used by DSM-V. However, functional connectivity networks 
differed between individual symptoms, between individual symptoms and total negative 
symptoms, and between individual symptoms and the two-factor model, suggesting that the use 
of broad categories obfuscates the relationship between symptom severity and functional 
connectivity.  
3.4.2 Patients vs. Healthy Controls 
As expected, schizophrenia patients showed wide-spread connectivity differences from 
healthy controls. Unlike our findings using the auditory oddball task, patients experienced both 
decreased connectivity in some networks and increased connectivity in others. Dysconnectivity 
was primarily identified within networks comprised of sensory processing and limbic networks, 
however decreased connectivity was found in a network consisting of the anterior cingulate and 
lateral parietal cortex, which are thought to comprise a SN [86, 131]. Both increased and 
decreased connectivity were identified within sensory processing networks, with decreased 
connectivity being found between early sensory regions and prefrontal, insular, and cingulate 
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regions, suggesting decreased top-down control over sensory processing. In contrast, increased 
connectivity was found between both early and late sensory processing centers and the thalamus, 
striatum, and hippocampus, suggesting an increase in bottom-up and involuntary control over 
sensory processing, consistent with the aberrant salience model of schizophrenia [40, 41, 143]. In 
the healthy brain, the process of selective attention amplifies task-relevant or otherwise salient 
information while silencing irrelevant sensory noise in order to maintain a robust signal-to-noise 
ratio. In the aberrant salience model, irrelevant information is treated as important due to a 
failure of a top-down silencing of sensory information within sensory processing networks, 
increasing the noise and leading to broad information processing and perceptual problems.  
3.4.3 Relationship between Connectivity and Negative Symptoms  
Overall, functional connectivity was associated with symptom severity within widespread, but 
relatively consistent networks. As expected, we found that functional connectivity within the 
regions of the DMN, limbic system, striatum, and SN were implicated by at least one category of 
negative symptoms. The relationship between negative symptoms and sensory processing 
networks was less expected. Sensory processing deficits have been previously reported in 
schizophrenia, and, as mentioned above, are consistent with the aberrant salience model, 
suggesting that they may serve a major role in the generation of negative symptoms. For 
instance, connectivity in the cuneus and other occipital cortex regions were correlated with every 
category of negative symptom tested except for the alogia and avolition/apathy domains. 
Similarly, Heschl’s gyrus and superior temporal cortex regions were correlated with total 
negative symptoms, flat affect, anhedonia asociality, and the Expression factor, but not alogia, 
avolition/apathy, or the Avolition factor. Within the contrast analysis, auditory networks were 
implicated for all of the symptom categories except for alogia and total negative symptoms. 
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However, alogia was correlated with activity in the fusiform gyrus, a visual processing 
area that was only correlated with alogia, and with the supramarginal gyrus, which is thought to 
be involved in auditory processing. Connectivity in the fusiform gyrus was only correlated with 
alogia, but the contrast analysis found altered fusiform connectivity associated with total 
negative symptoms (H>L), Alogia (H>L), and Avolition/Apathy (H>L & H<L). Likewise, the 
supramarginal gyrus, which is thought to be involved in auditory processing, was correlated with 
all of the negative symptom categories except for avolition/apathy. The contrast analysis found 
that connectivity in the supramarginal gyrus was altered in relationship to Expression factor 
(H<L), Flat Affect (H<L), avolition/apathy (H>L & H<L), and anhedonia/asociality (H>L & 
H<L). It is clear that sensory processing, especially visual and auditory processing networks are 
implicated in the negative symptoms, however, perhaps surprisingly, alogia seems to be 
specifically related to high-level visual processing regions such as the fusiform gyrus and 
inferior temporal cortex rather than auditory processing regions. Connectivity in temporal pole, a 
region involved in both visual and auditory processing, was associated with alogia, but in our 
results, temporal pole is connected within a network that includes inferior temporal cortex and 
occipital regions and is therefore likely part of a visual processing network rather than an 
auditory one. That being said, the visual processing regions that show altered connectivity 
associated with alogia are found in networks that are centered on limbic regions such as the 
amygdala and hippocampus, suggesting that we may be seeing a network involved more 
generally in association rather than strictly visual object recognition, or more simply, as we see 
decreased connectivity between these regions and amygdala and increased connectivity between 
these regions and hippocampus, that we are ultimately seeing a network underlying deficits in 
affective control over association cortices.  
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If we understand the biology behind alogia as aberrant affective control over sensory and 
association cortices, it’s categorization within the Expression factor makes sense. On this front, 
the correlation and contrast analyses of flat affect, alogia, and the Expression factor are difficult 
to parse. In the correlation analysis, flat affect was associated with increased connectivity in 
orbital-frontal, insula, medial parietal, and striatal regions. In the contrast analysis, connectivity 
was reduced in a similar set of regions in the high severity group, but decreased connectivity was 
found in a smaller network including posterior cingulate, temporal, occipital, and parietal cortex 
regions. The correlation with alogia found altered connectivity between the hippocampus and 
parahippocampus and temporal and parietal cortex regions and an association between 
supramarginal gyrus and bilateral caudate. In the contrast analysis, the high group showed 
increased connectivity in fronto-temporal networks and connectivity between midbrain structures 
and frontal and temporal cortex, while having decreased connectivity between the amygdala and 
occipital cortex regions. Overall, these findings suggest that flat affect and alogia are related to 
dysconnectivity in limbic areas such as the medial prefrontal cortex, amygdala, and 
hippocampus, striatal regions including the caudate and pallidum, and sensory processing areas 
such as the occipital cortex and superior temporal cortex. However, the Expression factor was 
correlated with networks that were primarily focused on the cingulate cortex and insula and 
included connectivity with lateral parietal cortex, putamen, and superior temporal cortex. The 
contrast analysis revealed a network that resembled the dorsal stream of visual processing for the 
Expression factor (H<L). Overall, the Expression factor encapsulated a similar set of networks, 
namely visual and auditory processing networks, the limbic system, and the striatum. The 
analyses that used the Expression factor identified different constitutive elements of these 
networks, failing to find limbic areas such as the amygdala, hippocampus, and parahippocampus 
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which were involved in flat affect and alogia, and likewise identifying the insula, which was not 
found to be correlated with either flat affect or alogia. 
Similarly, the Avolition factor was largely related to sensory processing regions in our 
analysis. In the correlation analysis, we found that the Avolition factor was almost exclusively 
associated with areas involved in visual processing. In the contrast analysis, the high group 
showed decreased connectivity in hippocampus, caudate, and visual processing regions along 
with auditory processing regions such as the superior temporal cortex. In contrast, the correlation 
analysis found that anhedonia/asociality was not only associated with connectivity in regions 
involved in visual and auditory processing, but also regions involved in the DMN. In the contrast 
analysis, avolition/apathy was also associated with not only sensory processing networks but also 
limbic and SN regions. Similarly, anhedonia/asociality was associated with sensory processing 
regions as well as limbic regions. These findings underscore the importance of sensory 
processing networks in negative symptoms, but also underscore the notion that the two-factor 
model of negative symptoms masks relevant neurobiological correlates of symptom severity.  
3.4.4 Correlation vs. Contrast Analysis 
Interestingly, the results from our correlation analysis were qualitatively different from 
the results of the contrast analysis. In our correlation analysis, we found only positive 
correlations between symptom severity and functional connectivity, whereas the contrast 
analysis found both increased and decreased connectivity in patients with high symptom 
severity. One possibility is that these findings have separated brain connectivity that is sensitive 
to the actual severity of negative symptoms from brain connectivity that is associated with the 
presence vs. absence of these symptoms. Another possibility is that because many of the same 
regions are implicated in both directions of the contrast analysis, that connectivity differences in 
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these regions are masked within the correlation analysis. However, for the most part, the 
networks implicated by the correlation analysis for each symptom were similar to those 
implicated by the contrast analysis, and we can likely be more certain that networks that were 
associated with a given symptom category in both analyses are showing a real interaction 
between symptom severity and functional connectivity. 
3.4.5 Summary 
Ultimately, the results of our functional connectivity study suggest that negative 
symptom severity is associated with altered connectivity in a broad set of brain networks and that 
individual negative symptoms show different patterns of functional connectivity. Furthermore, 
we found that functional connectivity correlates of negative symptoms are obscured when we use 
broad categories of symptoms such as total negative symptom severity or the Avolition and 
Expression factors.  In general, we found altered connectivity between striatal, limbic, SN, and 
DMN, as expected. However, our results were dominated by altered connectivity in sensory 
processing network, which was not expected. Dysconnectivity within sensory processing 
networks was preserved when symptoms were combined and ultimately were focused on visual 
and auditory processing, even in the absence of visual or auditory stimuli. Ultimately these 
findings support the aberrant salience model of schizophrenia, with prefrontal and SN regions 
showing decreased connectivity and bottom-up sensory networks involving the thalamus, limbic 
system, and striatum showing increased connectivity. 
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CHAPTER 4: DISCUSSION 
4.1 Summary 
In order to identify the relationship between severity of negative symptoms and 
functional brain activity, we carried out two experiments. The first explored the relationship 
between functional activation to the deviant tone of an auditory oddball task and negative 
symptom severity while the second explored the relationship between resting-state functional 
connectivity and negative symptom severity. Both studies found that functional activation was 
associated not only with the severity of total negative symptoms, but also that functional 
activation was associated with the severity of the individual symptom domains that comprise 
negative symptoms. The results of our two studies suggest that negative symptoms may be 
primarily associated with DMN and with sensory processing regions. 
We also tested a two-factor model of negative symptoms that has been supported by 
factor-analysis of schizophrenia symptoms and that will form the basis of DSM-V’s definition of 
negative symptoms [32, 38, 39, 96]. This model consisted of an Avolition factor and an 
Expression factor which we calculated by combining avolition/apathy and anhedonia/asociality 
as well as flat affect and alogia respectively. Interestingly, the auditory oddball study found that 
these factors were not significantly correlated with activity in any brain region in response to the 
deviant tone; however the resting-state analysis found a significant correlation between these two 
factors and a set of auditory and visual processing networks. In the resting-state study, however, 
the networks that were associated with these factors differed from the networks that were 
associated with their constitutive symptom domains. When combined with the failure to find any 
71 
 
correlated activation in the auditory oddball task, even when the constitutive symptom domains 
and total negative symptoms were found to be correlated with functional activation suggests that 
this two-factor model may not be well-suited towards functional imaging studies that are seeking 
to identify neural correlates of schizophrenia symptoms. Indeed, it seems likely that even though 
the symptom domains that comprise these factors may co-occur, that they reflect separate 
neurobiology and, when we combine the domains into a single factor, we obscure the 
relationship between symptoms and functional activity. 
4.2 The Role of the Central Executive Network 
Overall, negative symptoms were related to functional activation in and to functional 
connectivity between brain regions that form the default mode, limbic, striatal, salience, and 
sensory processing networks. Findings within these networks were identified in both studies, 
however somewhat surprisingly; there was not good evidence for a relationship between central 
executive network (CEN) regions such as the dorso-lateral prefrontal cortex and negative 
symptoms. This echoes the conclusions of the review article by Goghari et al. [64] and suggests 
that these regions may be more closely tied to cognitive symptoms rather than negative ones [45, 
64] and that earlier findings linking negative symptoms to these regions may be the result of 
confounding these two symptom categories [8, 33, 38]. More recent studies have been more 
selective in their categorization of negative and cognitive symptoms. In this study, for instance, 
we chose to exclude the attention deficit domain from the SANS for precisely this reason, as it is 
thought to be more closely related to cognitive rather than negative symptoms. The negative 
category of the PANSS is similarly problematic, as several of the negative items are more closely 
related to disorganization symptoms, and likewise, several items from the general category are 
more closely linked to negative symptoms [38]. Differences in negative symptom rating scale 
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usage may therefore underlie research findings implicating the dorso-lateral prefrontal cortex in 
negative symptoms.  
4.3 The Role of Limbic Networks 
We found a robust relationship between limbic regions and negative symptom severities 
in our resting-state analysis. A limbic network was correlated with total negative symptoms and 
was the only identified in the total negative symptom contrast analysis during resting state. 
Furthermore, limbic areas were related to all four negative symptom domains. Ultimately we 
might conclude that the shared feature of all negative symptoms is a failure of affective 
processing, with failures in both expression and volition being related to a failure to properly 
attribute affective importance. There was a qualitative difference between symptom domains in 
the extent of the associated limbic networks, with flat affect related to insula and ventro-medial 
prefrontal cortex; alogia related to hippocampus, parahippocampus, and amygdala; 
avolition/apathy related to parahippocampus, amygdala, and insula; and anhedonia/asociality 
related to parahippocampus, amygdala, and insula. These differences may suggest that different 
symptom domains are related to disruption of different affective processes. Dysconnectivity in 
amygdala, hippocampus, and parahippocampus could suggest inappropriate affective judgments 
or could suggest a failure to encode and retrieve affective information in memory. However, the 
latter explanation is more likely, as schizophrenia patients do not seem to have impaired 
experience of emotion [144].  The involvement of more anterior portions of the limbic system, 
namely the insula and ventro-medial prefrontal cortex may instead suggest deficits in the sense 
of self. Dysconnectivity in the insula has previously been shown to be associated with negative 
symptoms [86], and the involvement of the insula in flat affect, anhedonia/asociality, and 
avolition/apathy may represent the insula’s role as a hub that connects multiple networks or may 
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suggest a deficit in processing of sense of self. Identifying the precise nature of the role that the 
insula is playing would require better resolution than is provided by the AAL atlas, which treats 
the insula as a single region. A simple division between anterior and posterior insula may tell us 
more about whether its role here is more limbic or sensory in nature. However, in the context of 
negative symptoms, dissociation between the self and affective processing may also be present. 
Our results would support a model whereby negative symptoms reflect an inability to predict the 
usefulness of motivated behavior (including speech) and an inability to determine how affective 
judgments relate to the self, and this may indeed be one potential hypothesis for the underlying 
generation of negative symptoms. The auditory oddball study did not provide us much additional 
information about the limbic system, as limbic regions were only associated with 
anhedonia/asociality and no other negative symptom domains.  
4.4 The Role of the Default Mode Network 
Involvement of the DMN seems to differentiate between flat affect and alogia, which we 
might otherwise expect to reflect similar neural circuitry due to their membership in the 
expression factor, and may also differentiate between anhedonia/asociality and avolition/apathy, 
but this relationship is less clear. Our findings from the auditory oddball study suggest that 
avolition/apathy was associated with reduced activity in the precuneus and posterior cingulate in 
our correlation analysis, however no such relationship was found in the contrast analysis during 
the auditory oddball task or during the resting-state study. Likewise, DMN increased 
connectivity was correlated with total negative symptoms in the resting-state study, but was not 
found in the contrast between high and low symptoms, suggesting that differences in DMN may 
vary between symptom domains. Ultimately our findings may be explained by increased baseline 
activity in DMN which may be partially responsible for flat affect and anhedonia/asociality, but 
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may not be related to alogia or avolition/apathy. Increased connectivity in DMN has been found 
in schizophrenia in several studies [124, 127, 128, 136]. From the perspective of the aberrant 
salience model of schizophrenia, we might reduce the negative symptoms to a failure to maintain 
appropriate signal-to-noise-ratio for affective processes, with increased baseline activity in the 
DMN representing a failure to suppress noise during these processes, and altered connectivity in 
the limbic system representing a failure to identify and/or amplify the salient information [18, 41, 
86, 145]. Accordingly, the in individual negative symptom domains may represent different 
combinations of aberrant connectivity in the same set of brain regions. Such a model would 
explain why these symptoms tend to co-occur, but are not necessarily co-morbid, as analog 
disruptions in DMN, limbic, and sensory networks may create unique patterns of symptom 
severity across individual domains.  
4.5 Oddball Task vs. Resting State 
Interestingly, the direction of the relationships between negative symptoms and 
functional activation differed between the auditory oddball and resting-state studies. In the 
oddball study, we found that functional activation was negatively correlated with symptom 
severity and when we contrasted between high and low groups, we found that functional 
activation was decreased in the high severity group. In contrast, the resting-state study found 
only positive correlations between negative symptom severity and functional connectivity. 
Likewise, relationships between these variables in the contrast analysis occurred in both 
directions, with both increased and decreased connectivity being found in the high severity 
group. One way to interpret this is that schizophrenia patients experience a heightened baseline 
level of functional activity and functional connectivity. As a result of a heightened baseline, 
patients with more severe symptoms would show a smaller increase in activation in response to 
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task stimuli. This model is supported by findings in schizophrenia suggesting increased DMN 
connectivity [122, 124, 139] and by the aberrant salience model [40, 41, 143], as these networks 
are engaged by irrelevant stimuli that is treated as if it were important.  
Both studies identified a relationship between regions in the DMN, limbic system, 
striatum, SN, and sensory processing networks and negative symptom severity. As such, total 
negative symptoms were correlated with activity in the precuneus and posterior cingulate; insula, 
amygdala, and hippocampus; dorsolateral prefrontal cortex and lateral parietal cortex; and 
thalamus, cuneus, and superior temporal cortex respectively in response to the deviant tone on 
the oddball task, and a similar set of regions was correlated with total negative symptoms in the 
resting state analysis. Anhedonia/asociality was associated with a similar set of networks in both 
studies, while avolition/apathy showed fairly a fairly restricted correlation with functional 
activation to the deviant tone in the cuneus, precuneus, fusiform gyrus, and posterior cingulate 
and was found to be associated with connectivity in a similar set of regions in the contrast 
analysis during resting state. The results for flat affect and alogia were less consistent between 
studies. In the auditory oddball study, we found no relationship between flat affect and functional 
activation to the deviant tone, however flat affect was associated with functional connectivity in 
several networks in the resting-state study. Likewise, alogia was correlated with activity in the 
striatum in the auditory oddball task, but was more strongly related to limbic and sensory 
processing networks in the resting state study. It seems likely that task-performance biases the 
functional correlates of negative symptoms towards symptoms that are being more actively 
interrogated by the task. In this case, because the auditory oddball task lacked an emotional 
component, functional correlates of flattened affect along with affective circuitry associated with 
alogia weren’t associated with the deviant tone, and therefore weren’t identified in our analysis.  
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4.6 The Two-Factor Model of Negative Symptoms 
From the perspective of the two-factor model, the oddball task interrogated circuitry 
involved in the Avolition factor, but not the Expression factor, and as such we might interpret 
need to consider that alogia is not solely a member of the Expression factor as has been 
suggested by some [96]. Thus, our findings from the auditory oddball task may reflect the 
motivational aspects of alogia rather than the symptom as a whole, and further suggest that the 
symptom domains that we used for our study may be separated further. In contrast with the 
auditory oddball task, the resting-state functional connectivity study should have been free from 
bias towards any particular negative symptom category. This is supported by the fact that we 
identified neural correlates of flat affect and found a relationship between alogia and limbic 
areas, however we failed to find a relationship between avolition/apathy and functional 
activation in the correlation analysis, despite the presence of a relationship in our contrast 
analysis. This may suggest that task-performance is a double-edged sword, as task performance 
may both enhance the measurable relationship between some symptoms and functional 
activation while silencing others. Researchers should therefore be careful to select tasks that will 
amplify the variables they intend on measuring or be sure to utilize unbiased approaches such as 
resting-state connectivity analysis only when they have a sufficiently large sample size.  
4.7 Conclusions 
In conclusion, our findings suggest that negative symptoms are associated with relatively 
broad changes in functional activation and connectivity throughout the brain and that these 
changes are associated with limbic, striatal, default mode, salience, and sensory processing 
networks. Furthermore, individual symptom domains are associated with changes in functional 
activity and connectivity within these networks and that the patterns of these associations differ 
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between individual symptom domains. Likewise, the relationship between neural activity and 
two symptom factors comprised of the avolition/apathy and anhedonia/asociality domains and 
flat affect and alogia domains respectively were less clear, suggesting that studies that investigate 
the neural correlates of negative symptoms would be better off exploring individual symptom 
domains rather than combinations of these domains into larger categories such as these symptom 
factors or total negative symptoms. It may also be the case that these domains similarly are 
obfuscating the functional correlates of their respective parts, however research studies must 
balance the number of variables that they explore with their sample size. The data sets used in 
this study provided a unique opportunity to explore these symptom domains due to their 
relatively large size with 89 and 172 schizophrenia patients respectively. Finally, our findings 
suggested a strong relationship between negative symptom severity and functional activity and 
connectivity in sensory processing regions and networks. This finding support the aberrant 
salience model of schizophrenia and suggest that negative symptoms may be the result of early 
sensory processing. Clinically, deficits in sensory processing and salience attribution suggest that 
cognitive therapies may have some usefulness in treating or at least alleviating the effects of 
negative symptoms. Along those lines, our findings suggest that therapies that specifically focus 
on training individuals to filter out non-salient sensory information may be of some benefit. 
Neurobiologically, our findings suggest treatments that focus on either enhancing top-down 
control over these networks or in suppressing bottom-up processing. While this may be 
pharmacologically difficult, implanted electrode arrays may be able to achieve these therapeutic 
goals. However, such treatment is relatively invasive and would require significant research into 
the appropriate tuning for such arrays. Another possible technique may be transcranial magnetic 
stimulation (TMS). TMS is less invasive than implanted electrode arrays, but offers less fine-
78 
 
grained temporal and spatial control. TMS has been shown to be effective in treating depression  
[146], and targeting regions involved in the control of sensory processing may be beneficial in 
reducing negative symptoms in schizophrenia. 
4.8 Limitations 
The main limitation of these methods is that they do not allow us to determine whether 
differences in functional activity and connectivity that are related to negative symptoms cause or 
are caused by those symptoms. It’s entirely possible, for instance, that the observed activity and 
connectivity is the result of compensatory mechanisms and are ultimately the result of chronic 
illness and/or the presence of negative symptoms. 
The current study also does not entirely rule out medication effects. While in the second 
study, the correlations and contrasts included anti-psychotic drug dosage as a covariate, the 
auditory oddball study did not, as this data was not available. However, even when controlling 
for current dosages, we can’t rule out the effects of previous treatment nor can we rule out brain 
changes that arrive due to chronic treatment. The treatment-resistance of the negative symptoms 
is a strength of this current study, however, as we would not expect medication to effect the 
presence and severity of these symptoms and furthermore, might expect that any drug effects on 
negative symptoms that did occur would be a change in secondary, rather than primary 
symptoms.  
4.9 Future Directions 
The results of these two studies suggest several future directions for continued 
exploration of the neural correlates of negative symptoms. First, these two studies also include a 
rather large set of structural and diffusion DTI data. In the light of previous studies that have 
found a correlation between the severity of negative symptoms and grey matter thickness [51-54, 
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63], white matter integrity[55], and fractional anisotropy [56-62], an obvious extension of this 
work is to test the relationship between individual symptom domains and these structural 
measures. Furthermore, while DTI and functional connectivity do not show a strong relationship 
in healthy participants, there is some evidence that suggests an increased correlation between 
structural and functional connectivity in schizophrenia patients [140, 147]. Testing whether 
differences in this relationship are correlated with negative symptom severity may indicate 
whether changes in functional connectivity are related to large-scale (e.g. white matter tracts) or 
small-scale (e.g. synaptic differences) changes in connectivity.  
In light of other findings implicating the insula and DMN [86, 145], it might be valuable 
to perform a more targeted analysis of the insula by dividing it into smaller anatomical regions 
and then using these regions in a seed-based functional connectivity analysis. Furthermore, 
qualitatively, individual symptom domains differed from each other in terms of network 
connectivity according to anterior-posterior divisions of the limbic system. Analysis within this 
network comparing anterior portions of the limbic system such as the orbital prefrontal cortex 
and the insula with more posterior regions such as the amygdala and hippocampus may help to 
elucidate the biological differences between individual negative symptom domains.  
Our findings in the CEN were conflicted, with our auditory oddball task finding a 
significant correlation between dorsolateral prefrontal cortex and negative symptoms, while our 
resting-state study did not. The review by Goghari et al. [64] suggests that negative symptoms 
are not correlated with dorsolateral prefrontal cortex, but our findings contradict their findings. 
One possible explanation is that in our data set, these activations are reflecting the influence of 
cognitive disorganization symptoms on task performance during the deviant tone. This could be 
further explored by incorporating disorganization symptoms into our statistical models as a 
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covariate in order to remove their effects on the data. We might also seek to learn more about the 
networks that have been identified as correlated with negative symptoms. Further exploration 
into network topology, connectivity motifs, small-worldness, clustering, efficiency, etc. [89, 131] 
may tell us more about how these networks are disturbed and provide insight into whether they 
contribute to the generation of clinical symptoms or are instead a result of it. 
Our findings also suggest that task-completion may significantly alter the measurable 
correlates of negative symptoms. For instance, we found a correlation between dorsolateral 
prefrontal cortex and negative symptoms in the auditory oddball task, but not during resting-
state. Further studies that answer whether task performance changes the measurable neural 
correlates would help us answer whether the observed correlates of negative symptoms are 
related to state vs. trait. The simplest way to explore this relationship would be to measure 
functional connectivity and task-related activity separately for subjects during the performance 
of a task and then testing the correlation between negative symptoms and both the connectivity 
and activation results. This could also be addressed by measuring the functional correlates of 
negative symptoms using a set of behavioral tasks that are systematically chosen in order to 
interrogate various cognitive functions such as working memory, attention, reward, emotional 
processing, etc. in order to see how task-type affects the observed neural correlates of negative 
symptoms. 
The relationship between negative symptoms and networks thought to be primarily 
involved in sensory processing was a novel finding in these studies. Future investigation into 
these sensory networks may help elucidate the underlying neurobiology of negative symptoms. 
To do this, we could employ tasks that specifically target sensory processing in schizophrenia or, 
perhaps more interestingly, we could attempt to measure whether sensory processing deficits 
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predict negative symptom severity through the use of computational modeling and machine 
learning. Such a study could be carried out using only behavioral and clinical data, however an 
analysis that attempts to use resting state connectivity and/or functional activity during sensory 
processing tasks along with behavioral data and clinical data would ultimately allow us to 
explore the relationship between clinical symptoms, sensory processing deficits, and connectivity 
and activity in sensory processing networks.    
Ultimately, many of the negative symptoms are shared by other psychiatric disorders, and 
determining whether the neural correlates of these symptoms are shared between disorders would 
ultimately be an important step in understanding the biological features of psychiatric illness. 
Mood disorders in particular share many of these symptoms, and so an important follow-up to 
this project would be to explore how shared symptoms such as anhedonia are related to 
functional activity and connectivity in different psychiatric illnesses. 
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